<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>Current Neurology and Neuroscience Reports via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Current Neurology and Neuroscience Reports' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Current+Neurology+and+Neuroscience+Reports&t=Current+Neurology+and+Neuroscience+Reports&s=Search&f=source]]></link>
        <lastBuildDate>Fri, 19 Mar 2010 17:57:59 +0100</lastBuildDate>
        <item>
            <title>Management of Low-Grade Glioma</title>
            <link>http://www.medworm.com/index.php?rid=3382555&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7684v435q5213j48%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The optimal management of patients with low-grade glioma (LGG) is controversial. The controversy largely stems from the lack
 of well-designed clinical trials with adequate follow-up to account for the relatively long progression-free survival and
 overall survival of patients with LGG. Nonetheless, the literature increasingly suggests that expectant management is no longer
 optimal. Rather, there is mounting evidence supporting active management including consideration of surgical resection, radiotherapy,
 chemotherapy, molecular and histopathologic characterization, and use of modern imaging techniques for monitoring and prognostication.
 In particular, there is growing evidence favoring extensive surgical resection and increasing interest in the role of chemotherapy
...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3382555</comments>
            <pubDate>Wed, 17 Mar 2010 15:51:58 +0100</pubDate>
            <guid isPermaLink="false">3382555</guid>        </item>
        <item>
            <title>Synapse Pathology in Psychiatric and Neurologic Disease</title>
            <link>http://www.medworm.com/index.php?rid=3382556&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx6p453640765r50h%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Inhibitory and excitatory synapses play a fundamental role in information processing in the brain. Excitatory synapses usually
 are situated on dendritic spines, small membrane protrusions that harbor glutamate receptors and postsynaptic density components
 and help transmit electrical signals. In recent years, it has become evident that spine morphology is intimately linked to
 synapse function—smaller spines have smaller synapses and support reduced synaptic transmission. The relationship between
 synaptic signaling, spine shape, and brain function is never more apparent than when the brain becomes dysfunctional. Many
 psychiatric and neurologic disorders, ranging from mental retardation and autism to Alzheimer’s disease and addiction, are
 accompanied by alterati...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3382556</comments>
            <pubDate>Wed, 17 Mar 2010 15:51:57 +0100</pubDate>
            <guid isPermaLink="false">3382556</guid>        </item>
        <item>
            <title>Rehabilitation After Stroke: Current State of the Science</title>
            <link>http://www.medworm.com/index.php?rid=3363602&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F166l050374401174%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Stroke rehabilitation is evolving into a clinical field based on the neuroscience of recovery and restoration. There has been
 substantial growth in the number and quality of clinical trials performed. Much effort now is directed toward motor restoration
 and is being led by trials of constraint-induced movement therapy. Although the results do not necessarily support that constraint-induced
 movement therapy is superior to other training methods, this treatment has become an important vehicle for developing clinical
 trial methods and studying the physiology underlying activity-based rehabilitation strategies. Other promising interventions
 include robotic therapy delivery, magnetic and electrical cortical stimulation, visualization, and constraint-driven aphasia
 ther...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3363602</comments>
            <pubDate>Fri, 12 Mar 2010 06:51:34 +0100</pubDate>
            <guid isPermaLink="false">3363602</guid>        </item>
        <item>
            <title>The Genetics of Pediatric Brain Tumors</title>
            <link>http://www.medworm.com/index.php?rid=3362298&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F0261r86246100018%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Brain tumors are the most common childhood solid malignancy and the leading cause of cancer-related death in children. Medulloblastoma,
 ependymoma, supratentorial primitive neuroectodermal tumors, and pilocytic astrocytoma are the most prevalent types, all of
 which are clinically, histologically, and genetically heterogeneous. Despite an incomplete molecular understanding of these
 tumors, we have made significant headway in the past 5&amp;nbsp;years in identifying and classifying important genetic alterations
 and pathways central to the disease process. This review summarizes our current state of knowledge, emphasizes recent seminal
 findings in the field, and proposes future research efforts needed to further characterize the genetic basis of pediatric
 brain tumors.
 ...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3362298</comments>
            <pubDate>Thu, 11 Mar 2010 18:26:48 +0100</pubDate>
            <guid isPermaLink="false">3362298</guid>        </item>
        <item>
            <title>Congenital Muscular Dystrophies: Toward Molecular Therapeutic Interventions</title>
            <link>http://www.medworm.com/index.php?rid=3362299&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F1u0j0g61q8822m2u%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Congenital muscular dystrophies (CMDs) are a clinically and genetically heterogeneous group of neuromuscular disorders that
 typically present at birth or in early infancy with hypotonia, weakness, and histologic evidence of a dystrophic myopathy.
 CMD biochemical types include various abnormalities of α-dystroglycan O-mannosyl glycosylation as well as defects in integrin matrix receptors, the extracellular matrix proteins laminin-α2 and collagen VI, nuclear proteins such as lamin A/C, and a protein of the endoplasmic reticulum, selenoprotein N. Current
 therapies are directed mostly at supportive care; however, recent advances in biotechnology and increased knowledge of the
 pathophysiology underlying the various CMD types have helped identify potential therapeutic s...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3362299</comments>
            <pubDate>Thu, 11 Mar 2010 02:37:04 +0100</pubDate>
            <guid isPermaLink="false">3362299</guid>        </item>
        <item>
            <title>Advances in Pediatric Neurovirology</title>
            <link>http://www.medworm.com/index.php?rid=3362300&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fnn02m48424255x4g%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Viral infections of the pediatric central nervous system (CNS) encompass a broad spectrum of both perinatally and postnatally
 acquired diseases with potentially devastating effects on the developing brain. In children, viral infections have been associated
 with chronic encephalopathy, encephalitis, demyelinating disease, tumors, and epilepsy. Older diagnostic techniques of biopsy,
 viral culture, electron microscopy, gel-based polymerase chain reaction (PCR), and viral titer quantification are being replaced
 with more rapid, sensitive, and specific real-time and microarray-based PCR technologies. Advances in neuroimaging technologies
 have provided for earlier recognition of CNS injury without elucidation of specific viral etiology. Although the mainstay
 therapy of ...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3362300</comments>
            <pubDate>Thu, 11 Mar 2010 02:24:10 +0100</pubDate>
            <guid isPermaLink="false">3362300</guid>        </item>
        <item>
            <title>Utility of Skin Biopsy to Evaluate Peripheral Neuropathy</title>
            <link>http://www.medworm.com/index.php?rid=3358720&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F1u3r62001t697v70%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Skin biopsy for epidermal nerve fiber analysis provides an important objective test for the diagnosis of peripheral neuropathy,
 particularly small fiber sensory neuropathy (SFSN). The determination of epidermal nerve fiber density (ENFD) is reliable,
 with high diagnostic specificity and good sensitivity. Because of false negatives, biopsy results must be interpreted in conjunction
 with neurologic findings and laboratory results, including objective tests of sensory and autonomic function. SFSN most commonly
 is length dependent and is idiopathic in about half the patients. Biopsy of a proximal site (thigh) and a distal site (calf)
 typically shows greater abnormality of ENFD distally than proximally. More severe abnormality of ENFD in the thigh than in
 the calf rais...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3358720</comments>
            <pubDate>Wed, 10 Mar 2010 15:32:06 +0100</pubDate>
            <guid isPermaLink="false">3358720</guid>        </item>
        <item>
            <title>Management of Intraventricular Hemorrhage</title>
            <link>http://www.medworm.com/index.php?rid=3338098&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk15x5441206kt325%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Brain hemorrhage is the most fatal form of stroke and has the highest morbidity of any stroke subtype. Intraventricular extension
 of hemorrhage (IVH) is a particularly poor prognostic sign, with expected mortality between 50% and 80%. IVH is a significant
 and independent contributor to morbidity and mortality, yet therapy directed at ameliorating intraventricular clot has been
 limited. Conventional therapy centers on managing hypertension and intracranial pressure while correcting coagulopathy and
 avoiding complications such as rebleeding and hydrocephalus. Surgical therapy alone has not changed the natural history of
 the disease significantly. However, fibrinolysis in combination with extraventricular drainage shows promise as a technique
 to reduce intraventricul...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3338098</comments>
            <pubDate>Wed, 03 Mar 2010 08:07:54 +0100</pubDate>
            <guid isPermaLink="false">3338098</guid>        </item>
        <item>
            <title>Therapeutic Strategies for Diabetic Neuropathy</title>
            <link>http://www.medworm.com/index.php?rid=3331105&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fht7873p72212j3p7%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Diabetes is the leading cause of peripheral neuropathy globally. Duration of diabetes, glycemic control, and preexisting cardiovascular
 risk factors independently correlate with the development and progression of diabetic peripheral neuropathy as well as cardiovascular
 autonomic neuropathy. The pathogenesis of diabetic neuropathy remains unclear, although insulin resistance, oxidative stress,
 mitochondrial dysfunction, abnormal glucose metabolism, advanced glycation end products, neurotrophic factors, and protein
 kinase C activation all may play a role. Strict glycemic control remains the only available treatment option, although other
 treatments are in development. Multiple options are available for symptom management. In this article, we review factors associated...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3331105</comments>
            <pubDate>Tue, 02 Mar 2010 10:07:51 +0100</pubDate>
            <guid isPermaLink="false">3331105</guid>        </item>
        <item>
            <title>The Association of Migraine with Ischemic Stroke</title>
            <link>http://www.medworm.com/index.php?rid=3316033&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fnh7ll4q62560q146%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Migraine is a common, chronic–intermittent primary headache disorder affecting mostly women. The migraine pathophysiology
 involves both the neuronal and vascular systems, and in some patients, transient neurologic symptoms occur, which are known
 as migraine aura. A large body of literature supports an association between migraine and ischemic stroke, which is apparent
 mostly in young women with migraine with aura. Further increased risks have been observed particularly in smokers and women
 who use oral contraceptives. The vast majority of individual studies, as well as a recent meta-analysis, did not find an association
 between migraine without aura and ischemic stroke. Although there are several hypotheses about potential biological mechanisms
 linking migraine ...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3316033</comments>
            <pubDate>Fri, 26 Feb 2010 09:44:19 +0100</pubDate>
            <guid isPermaLink="false">3316033</guid>        </item>
        <item>
            <title>A Diagnostic Algorithm for Metabolic Myopathies</title>
            <link>http://www.medworm.com/index.php?rid=3316034&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F6h860713x58m8573%2F</link>
            <description>This article
 briefly reviews general clinical aspects of metabolic myopathies and highlights approaches to diagnosing the relatively more
 frequent subtypes (Fig.&amp;nbsp;1).
 
 
 Fig.&amp;nbsp;1&amp;nbsp;Clinical algorithm for patients with exercise intolerance in whom a metabolic myopathy is suspected. CK—creatine kinase; COX—cytochrome
 c oxidase; CPT—carnitine palmitoyl transferase; cyt b—cytochrome b; mtDNA—mitochondrial DNA; nDNA—nuclear DNA; PFK—phosphofructokinase; PGAM—phosphoglycerate mutase; PGK—phosphoglycerate kinase;
 PPL—myophosphorylase; RRF—ragged red fibers; TFP—trifunctional protein deficiency; VLCAD—very long-chain acyl–coenzyme A dehydrogenase
 
 
 
 
 
	Content Type Journal ArticleDOI 10.1007/s11910-010-0096-4Authors
		Andres Berardo, Columbia Univer...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3316034</comments>
            <pubDate>Fri, 26 Feb 2010 09:44:18 +0100</pubDate>
            <guid isPermaLink="false">3316034</guid>        </item>
        <item>
            <title>Spinal Muscular Atrophy: New and Emerging Insights from Model Mice</title>
            <link>http://www.medworm.com/index.php?rid=3316035&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy5542100614pg337%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Spinal muscular atrophy (SMA) is a common and often fatal neurodegenerative disease that primarily afflicts infants and young
 children. SMA is caused by abnormally low levels of the survival motor neuron (SMN) protein resulting from a combination of
 recessively inherited mutations in the SMN1 gene and the presence of an almost identical but partially functional copy gene, SMN2. Absence of the uniquely human SMN2 gene in SMA patients has never been reported because the SMN protein is indispensable for cell survival. Modeling SMA in
 animals therefore poses a challenge. This review describes the different strategies used to overcome this hurdle and model
 SMA in mice. We highlight new and emerging insights regarding SMA gained by studying the mice and illustrate how the...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3316035</comments>
            <pubDate>Thu, 25 Feb 2010 17:58:50 +0100</pubDate>
            <guid isPermaLink="false">3316035</guid>        </item>
        <item>
            <title>A First Step in Viral Gene Therapy for Muscular Dystrophy</title>
            <link>http://www.medworm.com/index.php?rid=3314518&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm2u332x5p6578m58%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trial ReportDOI 10.1007/s11910-010-0090-xAuthors
		Michio Hirano, Columbia University Medical Center 630 West 168th Street, P&amp;S 4-423 New York NY 10032 USA
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3314518</comments>
            <pubDate>Thu, 25 Feb 2010 08:02:34 +0100</pubDate>
            <guid isPermaLink="false">3314518</guid>        </item>
        <item>
            <title>New Daily Persistent Headache in Children and Adolescents</title>
            <link>http://www.medworm.com/index.php?rid=3311424&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F712t745047418u06%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;New daily persistent headache (NDPH) is a form of chronic daily headache (CDH) that may have features of both migraine and
 tension-type headache. In contrast with other types of CDH, NDPH is characterized by patients recalling the specific date
 their unremitting daily headache began. In comparison, chronic tension-type headache and chronic migraine are preceded by
 a gradually increasing frequency of headache. After several months, all three of these CDH forms often have a similar phenotype,
 making early history a key to diagnosing NDPH. Evaluations to exclude secondary causes are necessary but usually negative.
 NDPH is difficult to treat and requires a multimodal approach. Questions regarding NDPH remain unanswered. Additional prospective
 studies are necessary to ...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3311424</comments>
            <pubDate>Wed, 24 Feb 2010 06:55:48 +0100</pubDate>
            <guid isPermaLink="false">3311424</guid>        </item>
        <item>
            <title>Botulinum Toxin Type A for Chronic Migraine</title>
            <link>http://www.medworm.com/index.php?rid=3311423&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp06775u12k524647%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Chronic migraine (CM) is the leading cause of chronic daily headache, a common and debilitating headache syndrome. The management
 of CM patients is challenging, with only limited benefit from available oral preventive medications. Botulinum neurotoxin
 (BoNT) has been used extensively to treat disorders associated with increased muscle tone. More recent scientific data support
 an analgesic effect of the toxin. The pharmacokinetic and pharmacodynamic profiles of BoNT make it an appealing candidate
 for migraine prevention. Results from older clinical trials on the efficacy of the toxin in CM were inconclusive. However,
 recent trials using more stringent inclusion criteria have shown positive results, supporting the use of the toxin in some
 patients with this disorder...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3311423</comments>
            <pubDate>Wed, 24 Feb 2010 06:55:48 +0100</pubDate>
            <guid isPermaLink="false">3311423</guid>        </item>
        <item>
            <title>Antistreptococcal Antibodies Found in Patients with Narcolepsy</title>
            <link>http://www.medworm.com/index.php?rid=3311422&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp641150831204816%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trial ReportDOI 10.1007/s11910-010-0089-3Authors
		Michael Thorpy, Montefiore Medical Center Sleep-Wake Disorders Center 11 East 210th Street Bronx NY 10467 USA
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3311422</comments>
            <pubDate>Wed, 24 Feb 2010 06:55:48 +0100</pubDate>
            <guid isPermaLink="false">3311422</guid>        </item>
        <item>
            <title>Evolution of the Thrombolytic Treatment Window for Acute Ischemic Stroke</title>
            <link>http://www.medworm.com/index.php?rid=3197448&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F0476388664235075%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Ischemic stroke is a major cause of morbidity and mortality for which the only approved treatment in the acute setting is
 intravenous thrombolysis. The efficacy and safety of recombinant tissue plasminogen activator (rt-PA) have been firmly established
 within 3&amp;nbsp;h of symptom onset; however, few patients are eligible for treatment in this time window. Expanding the time for
 treatment has been challenging, but new evidence has demonstrated a modest statistical improvement in selected patients when
 rt-PA is administered within 4.5&amp;nbsp;h. This important finding hopefully will enable more patients to receive treatment and simultaneously
 provides an opportunity to reaffirm that the benefits of rt-PA diminish with time.
 
	Content Type Journal ArticleDOI 10.1007/s119...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3197448</comments>
            <pubDate>Tue, 19 Jan 2010 06:46:11 +0100</pubDate>
            <guid isPermaLink="false">3197448</guid>        </item>
        <item>
            <title>The Role of CT and MRI in the Emergency Evaluation of Persons with Suspected Stroke</title>
            <link>http://www.medworm.com/index.php?rid=3193583&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F70542783mv7w76k1%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;As a growing number of therapeutic treatment options for acute stroke are being introduced, multimodal acute neuroimaging
 is assuming a growing role in the initial evaluation and management of patients. Multimodal neuroimaging, using either a CT
 or MRI approach, can identify the type, location, and severity of the lesion (ischemia or hemorrhage); the status of the cerebral
 vasculature; the status of cerebral perfusion; and the existence and extent of the ischemic penumbra. Both acute and long-term
 treatment decisions for stroke patients can then be optimally guided by this information.
 
	Content Type Journal ArticleDOI 10.1007/s11910-009-0075-9Authors
		Chelsea S. Kidwell, Georgetown University Medical Center 4000 Reservoir Road, Northwest, Building D, Suite 150 Wa...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3193583</comments>
            <pubDate>Mon, 18 Jan 2010 18:25:19 +0100</pubDate>
            <guid isPermaLink="false">3193583</guid>        </item>
        <item>
            <title>Neural Injury in Sleep Apnea</title>
            <link>http://www.medworm.com/index.php?rid=3178654&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq82q8m0056g86866%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Sleepiness has long been recognized as a presenting symptom in obstructive sleep apnea syndrome, but persistent neurocognitive
 injury from sleep apnea has been appreciated only recently. Although therapy for sleep apnea markedly improves daytime symptoms,
 cognitive impairments may persist despite long-term therapy with continuous positive airway pressure. We know now that certain
 groups of neurons, typically those that are more metabolically active, are more vulnerable to injury than others. Animal models
 of sleep apnea oxygenation patterns have been instrumental in elucidating mechanisms of injury. The hypoxia/reoxygenation
 events result in oxidative, inflammatory, and endoplasmic reticulum stress responses in susceptible neural groups. With molecular
 pathways be...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3178654</comments>
            <pubDate>Wed, 13 Jan 2010 06:47:32 +0100</pubDate>
            <guid isPermaLink="false">3178654</guid>        </item>
        <item>
            <title>Early Decompressive Hemicraniectomy Following Malignant Ischemic Stroke: The Crucial Role of Timing</title>
            <link>http://www.medworm.com/index.php?rid=3171690&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2q83p5775qx32572%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trial ReportDOI 10.1007/s11910-009-0081-yAuthors
		Matthew Vibbert, Columbia University Medical Center Columbia University College of Physicians and Surgeons, New York Presbyterian Hospital, Neurological Institute Milstein Hospital Building, 177 Fort Washington Avenue, MHB-8-300 Center New York NY 10032 USAStephan A. Mayer, Columbia University Medical Center Columbia University College of Physicians and Surgeons, New York Presbyterian Hospital, Neurological Institute Milstein Hospital Building, 177 Fort Washington Avenue, MHB-8-300 Center New York NY 10032 USA
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3171690</comments>
            <pubDate>Tue, 12 Jan 2010 06:48:03 +0100</pubDate>
            <guid isPermaLink="false">3171690</guid>        </item>
        <item>
            <title>Tonabersat: A Cortical Spreading Depression Inhibitor as Potential Pharmacologic Prophylaxis in Migraine with Aura</title>
            <link>http://www.medworm.com/index.php?rid=3171691&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fdvu5675620q56t53%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trial ReportDOI 10.1007/s11910-009-0083-9Authors
		Ivan Garza, Mayo Clinic College of Medicine Department of Neurology 200 First Street Southwest Rochester MN 55905 USA
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3171691</comments>
            <pubDate>Mon, 11 Jan 2010 18:25:05 +0100</pubDate>
            <guid isPermaLink="false">3171691</guid>        </item>
        <item>
            <title>Radiation Therapy for Pediatric Low-Grade Gliomas: Survival and Sequelae</title>
            <link>http://www.medworm.com/index.php?rid=3171692&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3673480m3439g774%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trial ReportDOI 10.1007/s11910-009-0084-8Authors
		Roger J. Packer, Children’s National Medical Center Department of Neurology 111 Michigan Avenue Northwest Washington DC 20010 USA
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3171692</comments>
            <pubDate>Sun, 10 Jan 2010 06:54:03 +0100</pubDate>
            <guid isPermaLink="false">3171692</guid>        </item>
        <item>
            <title>Antistreptococcal Antibodies Found in Patients with Narcolepsy</title>
            <link>http://www.medworm.com/index.php?rid=3171693&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft077k04vj16p5227%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trial ReportDOI 10.1007/s11910-009-0073-yAuthors
		Michael Thorpy, Montefiore Medical Center Sleep-Wake Disorders Center 11 East 210th Street Bronx NY 10467 USA
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3171693</comments>
            <pubDate>Sun, 10 Jan 2010 06:54:00 +0100</pubDate>
            <guid isPermaLink="false">3171693</guid>        </item>
        <item>
            <title>Advances in the Diagnosis of Etiologic Subtypes of Ischemic Stroke</title>
            <link>http://www.medworm.com/index.php?rid=3171694&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj571106686286503%2F</link>
            <description>This article highlights important theoretical aspects of etiologic stroke classification and reviews
 major etiologic classification systems that have benefited from recent advances in etiologic stroke evaluation.
 
	Content Type Journal ArticleDOI 10.1007/s11910-009-0074-xAuthors
		Hakan Ay, Harvard Medical School Stroke Service and A. A. Martinos Center for Biomedical Imaging, Departments of Neurology and Radiology, Massachusetts General Hospital 149 13th Street, Room 2301 Charlestown MA 02129 USA
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3171694</comments>
            <pubDate>Sun, 10 Jan 2010 06:53:56 +0100</pubDate>
            <guid isPermaLink="false">3171694</guid>        </item>
        <item>
            <title>Nocturnal Leg Cramps</title>
            <link>http://www.medworm.com/index.php?rid=3163611&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft4m277015742j467%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Nocturnal leg cramps are a frequent cause of sleep disturbance among the general population, especially among the elderly.
 These painful episodes can delay sleep onset and awaken the patient from sleep, as well as delay subsequent return to sleep.
 Different mechanisms have been proposed to explain this phenomenon. Although most cases of leg cramps are idiopathic, multiple
 secondary causes of sleep-related leg cramps have been identified as well. In this article, we review the epidemiology, pathophysiology,
 and risk factors and discuss the salient features of the diagnosis and workup. Finally, we review the wide array of behavioral
 and pharmacologic treatments that have been studied for nocturnal leg cramps.
 
	Content Type Journal ArticleDOI 10.1007/s11910-009-0079...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3163611</comments>
            <pubDate>Fri, 08 Jan 2010 09:16:27 +0100</pubDate>
            <guid isPermaLink="false">3163611</guid>        </item>
        <item>
            <title>Utility of Functional MRI in Pediatric Neurology</title>
            <link>http://www.medworm.com/index.php?rid=3163610&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F35qqt6x2l148mt31%2F</link>
            <description>This article reviews the background of fMRI in pediatrics and highlights the most recent literature and clinical
 applications.
 
	Content Type Journal ArticleDOI 10.1007/s11910-009-0077-7Authors
		Emily R. Freilich, Children’s National Medical Center Department of Neurosciences 111 Michigan Avenue Northwest Washington DC 20010 USAWilliam D. Gaillard, Children’s National Medical Center Department of Neurosciences 111 Michigan Avenue Northwest Washington DC 20010 USA
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3163610</comments>
            <pubDate>Fri, 08 Jan 2010 09:16:27 +0100</pubDate>
            <guid isPermaLink="false">3163610</guid>        </item>
        <item>
            <title>Prevention of Stroke in Patients with High-Risk Atrial Fibrillation</title>
            <link>http://www.medworm.com/index.php?rid=3163612&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F46nx2142446l6874%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Atrial fibrillation (AF) causes nearly 10% of all ischemic strokes. Long-term oral anticoagulation with warfarin currently
 is the best treatment for preventing stroke in patients with AF and other stroke risk factors. However, many eligible patients
 do not receive warfarin, and some patients with AF are unsuitable for this treatment. Recent clinical trials have tested alternatives
 to long-term warfarin, and some new treatment options have emerged. Nonpharmacologic approaches to stroke prevention in atrial
 fibrillation also are under development. In addition, new diagnostic modalities may detect paroxysmal AF with more sensitivity,
 potentially expanding the population to be treated and the potential impact of stroke preventive strategies on the population.
 This rev...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3163612</comments>
            <pubDate>Thu, 07 Jan 2010 22:26:14 +0100</pubDate>
            <guid isPermaLink="false">3163612</guid>        </item>
        <item>
            <title>Seizures and Epilepsy in Cancer Patients</title>
            <link>http://www.medworm.com/index.php?rid=3156343&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg587917416575170%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Seizures in the general population may occur for a variety of reasons, including vascular, infectious, autoimmune, genetic,
 and traumatic causes. In the cancer population, seizures arise mainly as a result of an infiltrative neoplastic process in
 the brain. However, seizures as a result of cancer treatment, metabolic causes, or paraneoplastic diseases may occur in patients
 with systemic cancer, even in the absence of a cerebral lesion. The etiology of seizures in brain tumor patients includes
 primary cerebral neoplasms and metastatic brain lesions. The treatment for seizures in this population is multifaceted and
 involves surgery, radiation, chemotherapy, and antiepileptic drugs. All treatments have potential adverse effects, especially
 when combined. The treatmen...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3156343</comments>
            <pubDate>Wed, 06 Jan 2010 18:09:20 +0100</pubDate>
            <guid isPermaLink="false">3156343</guid>        </item>
        <item>
            <title>Ticagrelor, a New Antiplatelet Agent, for Prevention of Ischemic Events in Patients with Coronary Artery Disease</title>
            <link>http://www.medworm.com/index.php?rid=3156344&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fbx852863284681p0%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trial ReportDOI 10.1007/s11910-009-0082-xAuthors
		Harold P. Adams, University of Iowa Division of Cerebrovascular Diseases, Department of Neurology, University of Iowa Stroke Center 200 Hawkings Drive Iowa City IA 52242 USA
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3156344</comments>
            <pubDate>Tue, 05 Jan 2010 17:02:54 +0100</pubDate>
            <guid isPermaLink="false">3156344</guid>        </item>
        <item>
            <title>Neurogenic stunned myocardium</title>
            <link>http://www.medworm.com/index.php?rid=2898621&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F358g974404305130%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Neurogenic stunned myocardium may be defined as myocardial injury and dysfunction occurring after diverse types of acute brain
 injury as a result of imbalance of the autonomic nervous system. The spectrum of observed cardiac abnormalities includes electrocardiographic
 changes, arrhythmia, myocardial necrosis, release of B-type natriuretic peptide, and both systolic and diastolic dysfunction
 of the left ventricle. These are reversible abnormalities, and although management should include careful cardiac monitoring,
 treatments should generally focus on the underlying neurologic process to maximize neurologic recovery.
 
	Content Type Journal ArticleDOI 10.1007/s11910-009-0071-0Authors
		Hoang NguyenJonathan G. Zaroff, Kaiser San Francisco Medical Center Cardiology Dep...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2898621</comments>
            <pubDate>Tue, 13 Oct 2009 10:45:12 +0100</pubDate>
            <guid isPermaLink="false">2898621</guid>        </item>
        <item>
            <title>Management and prevention of human prion diseases</title>
            <link>http://www.medworm.com/index.php?rid=2898622&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft785p1v4h027751g%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Prion diseases are a group of fatal neurologic disorders that affect humans and animals and for which there is no available
 therapy. The basic pathogenic mechanism is linked to posttranslational changes of the host cellular prion protein (PrPc) into a pathologic conformer (PrPTSE) that has a strong tendency to aggregate and form amyloid fibrils. In humans, the most common form of the disease is sporadic
 Creutzfeldt-Jakob disease (CJD), which equally affects females and males of all ages and all ethnic groups. Sporadic CJD has
 an overall mortality rate of approximately one to two cases per million people per year, with peak incidence in individuals
 60 to 70 years old. Approximately 10% to 20% of CJD cases appear within families and are linked to point or insert mutat...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2898622</comments>
            <pubDate>Tue, 13 Oct 2009 10:45:11 +0100</pubDate>
            <guid isPermaLink="false">2898622</guid>        </item>
        <item>
            <title>Recent advances in the understanding of neglect and anosognosia following right hemisphere stroke</title>
            <link>http://www.medworm.com/index.php?rid=2898623&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F228x200h42v1tk52%2F</link>
            <description>This article highlights the latest findings regarding the cognitive-behavioral syndromes of neglect and anosognosia for hemiplegia
 that occur following right hemisphere stroke. We review papers published in the past 2 years pertaining to neurophysiology,
 assessment, and intervention for these two syndromes.
 
	Content Type Journal ArticleDOI 10.1007/s11910-009-0068-8Authors
		Kathleen Kortte, Johns Hopkins University School of Medicine Department of Physical Medicine and Rehabilitation 600 North Wolfe Street, Phipps 174 Baltimore MD 21205 USAArgye E. Hillis
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 6 / November, 2009 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2898623</comments>
            <pubDate>Tue, 13 Oct 2009 10:45:09 +0100</pubDate>
            <guid isPermaLink="false">2898623</guid>        </item>
        <item>
            <title>Management of intracranial pressure</title>
            <link>http://www.medworm.com/index.php?rid=2898624&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr6t10jn2t6140527%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Although intracranial hypertension may arise from diverse pathology, several basic principles remain paramount to understanding
 its dynamics; however, the management of elevated intracranial pressure (ICP) may be very complex. Initial management of common
 ICP exacerbants is important, such as addressing venous outflow obstruction with upright midline head positioning and treating
 agitation and pain with sedation and analgesia. Surgical decompression of mass effect may rapidly improve ICP elevation, but
 the impact on outcome is unclear. Considerable effort has been put forth to understand the roles of multimodal intensive care
 monitoring, osmolar therapy, cerebral metabolic suppression, and temperature augmentation in the advanced management of elevated
 ICP. Establ...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2898624</comments>
            <pubDate>Tue, 13 Oct 2009 10:45:08 +0100</pubDate>
            <guid isPermaLink="false">2898624</guid>        </item>
        <item>
            <title>Research with transcranial magnetic stimulation in the treatment of aphasia</title>
            <link>http://www.medworm.com/index.php?rid=2898625&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fqx4h2462h0761p18%2F</link>
            <description>We present language results from our rTMS studies as well as imaging results from overt naming
 functional MRI scans obtained before and after a series of rTMS treatments. Part 3 presents results from a pilot study in
 which rTMS treatments were followed immediately by constraint-induced language therapy. Part 4 reviews our diffusion tensor
 imaging study examining the possible connectivity of the arcuate fasciculus to different parts of Broca’s area (pars triangularis,
 pars opercularis) and to the ventral premotor cortex. The potential role of mirror neurons in the right pars opercularis and
 ventral premotor cortex in aphasia recovery is discussed.
 
	Content Type Journal ArticleDOI 10.1007/s11910-009-0067-9Authors
		Paula I. Martin, VA Boston Healthcare System Aphasia Research Center...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2898625</comments>
            <pubDate>Tue, 13 Oct 2009 10:45:07 +0100</pubDate>
            <guid isPermaLink="false">2898625</guid>        </item>
        <item>
            <title>Biological approaches to aphasia treatment</title>
            <link>http://www.medworm.com/index.php?rid=2898627&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F0n3u1417871mg21w%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In this review, we discuss the basic mechanisms of neural regeneration and repair and attempt to correlate findings from animal
 models of stroke recovery with clinical trials for aphasia. Several randomized controlled clinical trials involving manipulation
 of different neurotransmitter systems, including noradrenergic, dopaminergic, cholinergic, and glutamatergic systems, have
 shown signals of efficacy. Biological approaches such as anti-Nogo and cell replacement therapy have shown efficacy in preclinical
 models but have yet to reach proof of concept in the clinic. Finally, noninvasive cortical stimulation techniques have been
 used in a few small trials and have shown promising results. It appears that the efficacy of all these platforms can be potentiated
 through...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2898627</comments>
            <pubDate>Tue, 13 Oct 2009 10:45:06 +0100</pubDate>
            <guid isPermaLink="false">2898627</guid>        </item>
        <item>
            <title>Vascular dementia: A review of recent evidence for prevention and treatment</title>
            <link>http://www.medworm.com/index.php?rid=2898626&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg44r77553lk617m6%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Vascular dementia is a common cause of late-life cognitive decline. Vascular risk factors, transient is chemic attacks, silent
 and clinically evident strokes, and ischemic changes on brain imaging studies are all associated with the development of dementia.
 Prevention of vascular dementia involves treatment of risk factors and the same preventive measures used to avoid heart attacks
 and strokes. Other treatments for vascular dementia, although promising, remain unproved.
 
	Content Type Journal ArticleDOI 10.1007/s11910-009-0065-yAuthors
		Howard S. Kirshner, Vanderbilt University Medical Center Department of Neurology A-0118 Vanderbilt Medical Center North Nashville TN 37232 USA
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2898626</comments>
            <pubDate>Tue, 13 Oct 2009 10:45:06 +0100</pubDate>
            <guid isPermaLink="false">2898626</guid>        </item>
        <item>
            <title>Neurologic manifestations of varicella zoster virus infections</title>
            <link>http://www.medworm.com/index.php?rid=2898629&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff70231j08002755v%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Varicella zoster virus (VZV) causes acute viral exanthema in childhood, becomes latent, and can reactivate years later to
 produce neurologic disease. Primary VZV infection is associated with acute cerebellitis and stroke, particularly in childhood.
 VZV reactivation may result in neuropathy, myelitis, stroke, and encephalitis, the latter two syndromes the result of small
 and large vessel vasculopathy. Prompt diagnosis and treatment are critical to minimize morbidity in herpes zoster as well
 as morbidity and death in VZV vasculitis and encephalitis. Detection of anti-VZV antibodies in cerebrospinal fluid is the
 most sensitive method of diagnosing varicella infection of the nervous system. Despite the advent of the VZV vaccine, varicella
 remains a significant cause o...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2898629</comments>
            <pubDate>Tue, 13 Oct 2009 10:45:05 +0100</pubDate>
            <guid isPermaLink="false">2898629</guid>        </item>
        <item>
            <title>Status epilepticus</title>
            <link>http://www.medworm.com/index.php?rid=2898628&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp2v5012778886777%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Status epilepticus (SE) still results in significant mortality and morbidity. Whereas mortality depends mainly on the age
 of the patient as well as etiology, morbidity often results from a myriad of complications that occur during prolonged admission
 to an intensive care environment. Although SE is a clinical diagnosis in most cases (convulsant), its treatment requires support
 by continuous electroencephalographic recording to ensure cessation of potential nonconvulsive elements of SE. Treatment must
 be initiated as early as possible and consists of benzodiazepine administration and supportive measures for the airway and
 circulation. These initial interventions are followed by effective intravenous antiepileptic drugs. If the SE becomes refractory,
 more complex in...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2898628</comments>
            <pubDate>Tue, 13 Oct 2009 10:45:05 +0100</pubDate>
            <guid isPermaLink="false">2898628</guid>        </item>
        <item>
            <title>A cytomegalovirus vaccine</title>
            <link>http://www.medworm.com/index.php?rid=2898630&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx7878735g73j2620%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trials ReportDOI 10.1007/s11910-009-0072-zAuthors
		Burk Jubelt, Department of Neurology at SUNY Upstate Medical University Syracuse USA
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 6 / November, 2009 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2898630</comments>
            <pubDate>Tue, 13 Oct 2009 10:45:04 +0100</pubDate>
            <guid isPermaLink="false">2898630</guid>        </item>
        <item>
            <title>TDP-43 and frontotemporal dementia</title>
            <link>http://www.medworm.com/index.php?rid=2662385&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F24870600q887pg86%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;TAR DNA-binding protein of about 43 kDa (TDP-43) is the main ubiquitinated peptide in tau-negative frontotemporal lobar degeneration
 (FTLD). TDP-43 is typically a nuclear protein, and its aggregation and cytoplasmic translocation are thought to represent
 major steps in the pathogenesis of FTLD due to TDP-43 proteinopathy (FTLD-TDP). Certain clinical syndromes of frontotemporal
 dementia are preferentially associated with pathologic findings of FTLD-TDP, and TDP-43 pathology represents the connection
 between FTLD-TDP and amyotrophic lateral sclerosis. Recent advances in clinical, genetic, and pathologic studies of FTLD-TDP
 and amyotrophic lateral sclerosis have shed light on the potentially pathogenic role of TDP-43 and identified TDP-43 itself
 as a candidate biomar...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2662385</comments>
            <pubDate>Fri, 31 Jul 2009 18:13:54 +0100</pubDate>
            <guid isPermaLink="false">2662385</guid>        </item>
        <item>
            <title>Neuro-ophthalmology and the anti-GQ1b antibody syndromes</title>
            <link>http://www.medworm.com/index.php?rid=2662386&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh2k2657344877208%2F</link>
            <description>This article aims to bring together the historically disparate opinions on the origins of these syndromes as either a purely
 peripheral nervous system or central nervous system dysfunction, highlight the clinical neuro-ophthalmologic signs, discuss
 some of the biology of the anti-GQ1b antibody, and review imaging abnormalities and treatment of this fascinating disorder.
 
	Content Type Journal ArticleDOI 10.1007/s11910-009-0055-0Authors
		Robert F. Saul, University of Mississippi Medical Center Department of Neurology 2500 North State Street Jackson MS 39216 USA
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 5 / September, 2009 (Source: Current Neurology and Neuroscience Rep...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2662386</comments>
            <pubDate>Fri, 31 Jul 2009 18:13:53 +0100</pubDate>
            <guid isPermaLink="false">2662386</guid>        </item>
        <item>
            <title>An update on treatment and prevention strategies for Alzheimer’s disease</title>
            <link>http://www.medworm.com/index.php?rid=2662387&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F11u1625u70541176%2F</link>
            <description>This article discusses recent data on treatment strategies targeting
 amyloid and tau pathology. Novel therapeutic strategies such as inhibitors of receptors for advanced glycation end products
 (RAGE), potential mitochondrial modification with Dimebon, anti-inflammatory approaches, and cholesterol-lowering agents are
 also reviewed. An update on results from pharmacologic and nonpharmacologic prevention trials is provided.
 
	Content Type Journal ArticleDOI 10.1007/s11910-009-0054-1Authors
		Judith NeugroschlMary Sano, James J. Peters Veterans Affairs Medical Center 130 Kingsbridge Road, Room 1F01 Bronx NY 10468 USA
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 5 / September...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2662387</comments>
            <pubDate>Fri, 31 Jul 2009 18:13:52 +0100</pubDate>
            <guid isPermaLink="false">2662387</guid>        </item>
        <item>
            <title>Axonal degeneration in multiple sclerosis: The mitochondrial hypothesis</title>
            <link>http://www.medworm.com/index.php?rid=2662390&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F07115643n1377756%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Multiple sclerosis (MS) is a chronic disease of the central nervous system, affecting more than 2 million people worldwide.
 Traditionally considered an inflammatory demyelinating disease, recent evidence now points to axonal degeneration as crucial
 to the development of irreversible disability. Studies show that axonal degeneration occurs throughout the entire course of
 MS. Although the specific mechanisms causing axonal damage may differ at various stages, mitochondrial failure seems to be
 a common underlying theme. This review addresses the mitochondrial hypothesis for axonal degeneration in MS, highlighting
 the mechanisms by which mitochondrial dysfunction leads to axonal disruption in acute inflammatory lesions and the chronic
 axonopathy in progressive MS. Emp...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2662390</comments>
            <pubDate>Fri, 31 Jul 2009 18:13:51 +0100</pubDate>
            <guid isPermaLink="false">2662390</guid>        </item>
        <item>
            <title>Selected lid problems in neurologic practice</title>
            <link>http://www.medworm.com/index.php?rid=2662389&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F028184gg204vr351%2F</link>
            <description>This article reviews recent literature on some causes of ptosis
 and other lid conditions.
 
	Content Type Journal ArticleDOI 10.1007/s11910-009-0057-yAuthors
		Gregory S. Kosmorsky, Cole Eye Institute Cleveland Clinic 9500 Euclid Avenue, Mail Code I-30 Cleveland OH 44195 USAAlyssa Fiddler
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 5 / September, 2009 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2662389</comments>
            <pubDate>Fri, 31 Jul 2009 18:13:51 +0100</pubDate>
            <guid isPermaLink="false">2662389</guid>        </item>
        <item>
            <title>Epstein-barr virus in multiple sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=2662388&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fqv37535m524u5630%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Recent seroepidemiologic and pathologic evidence suggests that prior infection with Epstein-Barr virus (EBV) may be necessary
 for the development of multiple sclerosis (MS). EBV infects more than 90% of all humans, most of whom remain healthy. In contrast,
 99% of MS patients have evidence of prior infection with EBV. EBV infects resting B lymphocytes, immortalizing them into long-lived
 memory B cells that survive largely undetected by the immune system in the peripheral circulation. MS patients show elevated
 titers to EBV years before developing any neurologic symptoms. Postmortem pathologic analysis of brains of patients with MS
 has revealed diffuse EBV-associated B-cell dysregulation in all forms of MS. Theories of pathogenesis of EBV in MS include
 antigenic mim...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2662388</comments>
            <pubDate>Fri, 31 Jul 2009 18:13:51 +0100</pubDate>
            <guid isPermaLink="false">2662388</guid>        </item>
        <item>
            <title>Gray matter pathology and multiple sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=2662391&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp27711978h7un234%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Gray matter demyelination is frequent and extensive in most patients with multiple sclerosis (MS) and has recently received
 much attention in neuropathologic and imaging studies. Gray matter lesions show distinct pathologic features that make their
 detection difficult with conventional imaging techniques. Thus, despite their high prevalence, their impact on clinical symptoms
 has not been defined well so far. This review focuses on recent information from pathologic and imaging studies and summarizes
 our current knowledge on cortical pathology derived from human and experimental studies.
 
	Content Type Journal ArticleDOI 10.1007/s11910-009-0058-xAuthors
		Christiane WegnerChristine Stadelmann, University Medical Centre Institute of Neuropathology Robert-Koch-Str. 40...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2662391</comments>
            <pubDate>Fri, 31 Jul 2009 18:13:50 +0100</pubDate>
            <guid isPermaLink="false">2662391</guid>        </item>
        <item>
            <title>Update on amyloid imaging: From healthy aging to Alzheimer’s disease</title>
            <link>http://www.medworm.com/index.php?rid=2662392&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F78v2248783349764%2F</link>
            <description>We report on the current state of in vivo amyloid imaging. Although this technique is less than a decade old, a wealth of
 information is emerging as the initial clinical studies are being reported. Imaging of patients with Alzheimer’s disease has
 allowed quantitative exploration of the natural history of amyloid deposition and its relationship to neurodegeneration. Amyloid
 imaging also shows significant promise in the differential diagnosis of mild cognitive impairment or atypical dementias. However,
 amyloid detection may be of greatest utility in healthy elderly persons; consistent with prior autopsy studies, a significant
 proportion of asymptomatic individuals display increased levels of amyloid by in vivo imaging. Understanding the relationship
 between this pathology and future ...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2662392</comments>
            <pubDate>Fri, 31 Jul 2009 18:13:48 +0100</pubDate>
            <guid isPermaLink="false">2662392</guid>        </item>
        <item>
            <title>Current pharmacologic testing for horner syndrome</title>
            <link>http://www.medworm.com/index.php?rid=2662394&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe51r0425006k7257%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;First described in 1727, Horner syndrome occurs from injury to one of the three neurons in the oculo-sympathetic pathway.
 Its presence can be confirmed with pharmacologic testing, traditionally including cocaine testing with hydroxyamphetamine
 localization. More recently, apraclonidine testing has become a viable alternative in some practices. Concern has been raised
 regarding the possibility of false-negative results with apraclonidine testing as well as the safety of its use in young children.
 
	Content Type Journal ArticleDOI 10.1007/s11910-009-0056-zAuthors
		Mansoor MughalReid Longmuir, The University of Iowa Hospitals and Clinics Department of Ophthalmology and Visual Sciences 200 Hawkins Drive Iowa City IA 52242 USA
	

	
		Journal Current Neurology and Neuros...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2662394</comments>
            <pubDate>Fri, 31 Jul 2009 18:13:47 +0100</pubDate>
            <guid isPermaLink="false">2662394</guid>        </item>
        <item>
            <title>Immunologically mediated dementias</title>
            <link>http://www.medworm.com/index.php?rid=2662393&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn210u457878328vt%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Although most dementias are due to neurodegenerative or vascular disease, it is important to diagnose immunologically mediated
 dementias quickly because they can be both rapidly progressive and readily treatable. They usually affect function of limbic
 and cortical structures, but subcortical involvement can also occur. Because of the variety of symptoms and the rapid course,
 these dementias present a particular challenge to the clinician and may require evaluation and intervention in the inpatient
 setting. Diagnostic workup typically reveals evidence of an autoimmune process and, in some cases, cancer. In contrast to
 the neurodegenerative processes, many of the immunologically mediated dementias respond to immunomodulatory therapy.
 
	Content Type Journal ArticleDO...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2662393</comments>
            <pubDate>Fri, 31 Jul 2009 18:13:47 +0100</pubDate>
            <guid isPermaLink="false">2662393</guid>        </item>
        <item>
            <title>Alemtuzumab versus interferon beta-1a in early multiple sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=2662395&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fmk10n12630g72g21%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trials ReportDOI 10.1007/s11910-009-0062-1Authors
		Dennis Bourdette, Oregon Health &amp; Science University Department of Neurology Portland OR USAVijayshree Yadav, Oregon Health &amp; Science University Department of Neurology Portland OR USA
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 5 / September, 2009 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2662395</comments>
            <pubDate>Fri, 31 Jul 2009 18:13:45 +0100</pubDate>
            <guid isPermaLink="false">2662395</guid>        </item>
        <item>
            <title>Treating CNS sarcoidosis with infliximab and mycophenolate mofetil</title>
            <link>http://www.medworm.com/index.php?rid=2662396&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd6462635w0042786%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trials ReportDOI 10.1007/s11910-009-0061-2Authors
		James Corbett, University of Mississippi Medical Center Department of Neurology Jackson MS USA
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 5 / September, 2009 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2662396</comments>
            <pubDate>Fri, 31 Jul 2009 18:13:44 +0100</pubDate>
            <guid isPermaLink="false">2662396</guid>        </item>
        <item>
            <title>Cell-based therapies in Parkinson’s disease</title>
            <link>http://www.medworm.com/index.php?rid=2508371&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F46830643253633wx%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The possibility of using stem cells to treat Parkinson’s disease has excited physicians and patients alike. However, after
 many encouraging open-label studies of fetal cell transplantation for Parkinson’s disease, three randomized, double-blind,
 placebo-controlled studies found no net benefit. In addition, patients in two of the studies developed dyskinesias that persisted
 despite reductions in medication. To realize the promise of stem cells, research has been undertaken to understand and overcome
 the dual problems of unpredictable benefit and troublesome dyskinesias after dopaminergic cell transplantation.
 
	Content Type Journal ArticleDOI 10.1007/s11910-009-0044-3Authors
		Paul Greene, Columbia University Medical Center Department of Neurology 710 West 168th...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2508371</comments>
            <pubDate>Tue, 09 Jun 2009 14:35:36 +0100</pubDate>
            <guid isPermaLink="false">2508371</guid>        </item>
        <item>
            <title>Bioequivalence of antiepileptic drugs: How close is close enough?</title>
            <link>http://www.medworm.com/index.php?rid=2508374&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2g03672ht170ug24%2F</link>
            <description>This article reviews current regulatory requirements and pharmacokinetic, biopharmaceutical,
 and clinical outcome issues that clinicians, pharmacists, and policymakers should consider regarding generic substitution
 of these complicated agents.
 
	Content Type Journal ArticleDOI 10.1007/s11910-009-0050-5Authors
		Barry E. Gidal, University of Wisconsin School of Pharmacy and Department of Neurology 777 Highland Avenue Madison WI 53705 USA
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 4 / July, 2009 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2508374</comments>
            <pubDate>Tue, 09 Jun 2009 14:35:34 +0100</pubDate>
            <guid isPermaLink="false">2508374</guid>        </item>
        <item>
            <title>A controlled trial of antidepressants in patients with Parkinson’s disease and depression</title>
            <link>http://www.medworm.com/index.php?rid=2508373&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ftq706jnp5mp31506%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trials ReportDOI 10.1007/s11910-009-0038-1Authors
		John C. MorganKapil D. Sethi
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 4 / July, 2009 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2508373</comments>
            <pubDate>Tue, 09 Jun 2009 14:35:34 +0100</pubDate>
            <guid isPermaLink="false">2508373</guid>        </item>
        <item>
            <title>Is it time for drug sensitivity genetic screening?</title>
            <link>http://www.medworm.com/index.php?rid=2508372&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3966080601382487%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trials ReportDOI 10.1007/s11910-009-0040-7Authors
		Carl W. Bazil
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 4 / July, 2009 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2508372</comments>
            <pubDate>Tue, 09 Jun 2009 14:35:34 +0100</pubDate>
            <guid isPermaLink="false">2508372</guid>        </item>
        <item>
            <title>Paraneoplastic movement disorders</title>
            <link>http://www.medworm.com/index.php?rid=2508376&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F9046372j4nu82081%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Neurologic paraneoplastic syndromes (NPSs) result from damage to the nervous system due to the remote effects of cancer not
 related to metastasis, infection, or metabolic derangements. NPSs are rare, affecting 1 in 10,000 patients with cancer. Pathogenesis
 is likely related to the immune mechanisms: normal neural tissue is mistakenly attacked due to the similarity in the onconeural
 antigens expressed by the tumor cells. Among the various “classic” and other NPSs, this review focuses on paraneoplastic movement
 disorders, including ataxia due to cerebellar degeneration, stiffperson syndrome, opsoclonus-myoclonus syndrome, chorea, parkinsonism,
 and tremor. The recently described syndrome of paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis is also inc...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2508376</comments>
            <pubDate>Tue, 09 Jun 2009 14:35:33 +0100</pubDate>
            <guid isPermaLink="false">2508376</guid>        </item>
        <item>
            <title>Depression and epilepsy: Do glucocorticoids and glutamate explain their relationship?</title>
            <link>http://www.medworm.com/index.php?rid=2508375&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fhq717370661353k0%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Depression is the most common psychiatric comorbidity in people with epilepsy, but it remains underrecognized and undertreated.
 In addition to its negative impact on quality of life, depressive disorders are predictive of a worse response to pharmacologic
 and surgical treatment of seizure disorders. This phenomenon is probably an expression of a bidirectional relationship between
 epilepsy and depression, which in turn is indicative of common pathogenic mechanisms that are operant in the two conditions.
 The abnormal role of the hypothalamic-pituitary-adrenal axis is one of the common pathogenic mechanisms that explains why
 patients with depression are at greater risk for developing epilepsy and vice versa.
 
	Content Type Journal ArticleDOI 10.1007/s11910-009-0046-1...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2508375</comments>
            <pubDate>Tue, 09 Jun 2009 14:35:33 +0100</pubDate>
            <guid isPermaLink="false">2508375</guid>        </item>
        <item>
            <title>What’s new in dystonia?</title>
            <link>http://www.medworm.com/index.php?rid=2508377&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F14326821gm738425%2F</link>
            <description>This article reviews relevant recent findings in dystonia.
 
	Content Type Journal ArticleDOI 10.1007/s11910-009-0042-5Authors
		Vicki Shanker, Albert Einstein College of Medicine Beth Israel Medical Center 10 Union Square East, Suite 5J New York NY 10003 USASusan B. Bressman
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 4 / July, 2009 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2508377</comments>
            <pubDate>Tue, 09 Jun 2009 14:35:32 +0100</pubDate>
            <guid isPermaLink="false">2508377</guid>        </item>
        <item>
            <title>New insights into the organization of the basal ganglia</title>
            <link>http://www.medworm.com/index.php?rid=2508379&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F013153285478t840%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Understanding the functional organization of the basal ganglia requires a broad array of complementary theoretical models.
 Although the basal ganglia operate as part of a system of parallel cortico-basal ganglia-thalamocortical loops, there is clearly
 integration between the loops and there are probably more of these loops than previously conceived. Moreover, modulation by
 external inputs, particularly from the brainstem (eg, pedunculopontine nucleus, raphe nucleus, and locus coeruleus) adds to
 the complexity of the system. We now appreciate that the organization of the basal ganglia is not static and shows significant
 plasticity that allows the ganglia to function in learning processes and in response to age or disease, either as components
 of the pathophysiology...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2508379</comments>
            <pubDate>Tue, 09 Jun 2009 14:35:30 +0100</pubDate>
            <guid isPermaLink="false">2508379</guid>        </item>
        <item>
            <title>Epilepsy in the developing world</title>
            <link>http://www.medworm.com/index.php?rid=2508378&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F82h31267q2317727%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Developing countries (DCs) and developed countries have geographic, economic, and social differences. The prevalence and incidence
 of epilepsy are higher in DCs than in developed countries. However, within DCs, given the high incidence of epilepsy, the
 prevalence is relatively low, which may be due to high mortality for people with epilepsy (PWE). Neurocysticercosis is one
 of the main causes of symptomatic epilepsy in many DCs. Prognosis in DCs seems similar to that in developed countries. Because
 phenobarbital and phenytoin are available and inexpensive, they are the drugs most often used in DCs. The cost of newer antiepileptic
 drugs and the limited availability of resources for epilepsy care in DCs mean that care for PWE in DCs is marginalized and
 that many peop...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2508378</comments>
            <pubDate>Tue, 09 Jun 2009 14:35:30 +0100</pubDate>
            <guid isPermaLink="false">2508378</guid>        </item>
        <item>
            <title>Bilateral deep brain stimulation versus best medical therapy for patients with advanced Parkinson’s disease</title>
            <link>http://www.medworm.com/index.php?rid=2508382&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe818050223447724%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trials ReportDOI 10.1007/s11910-009-0039-0Authors
		Shyamal H. MehtaKapil D. Sethi
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 4 / July, 2009 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2508382</comments>
            <pubDate>Tue, 09 Jun 2009 14:35:28 +0100</pubDate>
            <guid isPermaLink="false">2508382</guid>        </item>
        <item>
            <title>An update on essential tremor</title>
            <link>http://www.medworm.com/index.php?rid=2508381&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn718m7748051xkh3%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Essential tremor is a well-defined syndrome of postural and kinetic tremor in a characteristic distribution. In some patients,
 impaired tandem walking, intention tremor, and rest tremor are also seen. An increasing body of clinical, neuropathological,
 and epidemiologic evidence suggests that essential tremor is a heterogeneous disorder. The evidence is discussed in this update.
 Recent advances in the treatment of this condition are also reviewed.
 
	Content Type Journal ArticleDOI 10.1007/s11910-009-0041-6Authors
		Rodger J. Elble, Southern Illinois University School of Medicine PO Box 19643 Springfield IL 62794 USAGünther Deuschl
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 9
	
		Journa...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2508381</comments>
            <pubDate>Tue, 09 Jun 2009 14:35:28 +0100</pubDate>
            <guid isPermaLink="false">2508381</guid>        </item>
        <item>
            <title>Alternative approaches to epilepsy treatment</title>
            <link>http://www.medworm.com/index.php?rid=2508380&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7207381270lw48q6%2F</link>
            <description>This article reviews the CAM modalities of meditation, yoga, relaxation techniques, biofeedback,
 nutritional and herbal supplements, dietary measures, chiropractic care, acupuncture, Reiki, and homeopathy and what is known
 about their potential efficacy in patients with epilepsy.
 
	Content Type Journal ArticleDOI 10.1007/s11910-009-0047-0Authors
		Caitlin McElroy-Cox, Columbia University, Neurologic Institute Columbia Comprehensive Epilepsy Center 710 West 168th Street, 7th Floor New York NY 10032 USA
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 4 / July, 2009 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2508380</comments>
            <pubDate>Tue, 09 Jun 2009 14:35:28 +0100</pubDate>
            <guid isPermaLink="false">2508380</guid>        </item>
        <item>
            <title>An update on brain stimulation for epilepsy</title>
            <link>http://www.medworm.com/index.php?rid=2508383&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F61g31g71550q34k4%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Brain stimulation for epilepsy has been explored for decades. Nevertheless, this area has traditionally been associated with
 small poorly controlled trials, inconsistent results, and a resultant lack of widespread use of these technologies. Due to
 the success of deep brain stimulation for movement disorders and unprecedented advances in computer technology and bioengineering,
 brain stimulation recently has again generated great interest in epilepsy care. Several large-scale, randomized, blinded,
 multicenter trials have been conducted; the most up-to-date findings are summarized in this article. These treatment modalities
 will likely improve over time. The hope that they provide to patients with refractory epilepsy cannot be underestimated.
 
	Content Type Journal A...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2508383</comments>
            <pubDate>Tue, 09 Jun 2009 14:35:27 +0100</pubDate>
            <guid isPermaLink="false">2508383</guid>        </item>
        <item>
            <title>Is GIGYF2 the defective gene at the PARK11 locus?</title>
            <link>http://www.medworm.com/index.php?rid=2402940&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F8282747061954046%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The number of genes and loci for Parkinson’s disease was expanded during 2008. Among the most interesting findings of the
 year was the nomination of GIGYF2 as the gene that is defective at the PARK11 locus and is a potentially frequent cause of typical Parkinson’s disease. However,
 the optimism generated by the initial report has quickly been tempered by results obtained in the first wave of follow-up
 studies.
 
	Content Type Journal ArticleDOI 10.1007/s11910-009-0028-3Authors
		Vincenzo Bonifati, Erasmus Medical Center Department of Clinical Genetics Box 2040 3000 CA Rotterdam The Netherlands
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 3 / May, 2...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2402940</comments>
            <pubDate>Sun, 05 Apr 2009 13:13:02 +0100</pubDate>
            <guid isPermaLink="false">2402940</guid>        </item>
        <item>
            <title>Neurofibromatosis type 1 and associated malignancies</title>
            <link>http://www.medworm.com/index.php?rid=2330152&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy7156755m12012h2%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Neurofibromatosis type 1 (NF1) is a common autosomal dominant neurocutaneous disorder with a predisposition to the development
 of benign and malignant tumors. Mutations in the NF1 gene result in loss of function of neurofibromin, a guanosine triphosphatase-activating protein that helps maintain the proto-oncogene
 Ras in its inactive form. Loss of neurofibromin results in increased proliferation and tumorigenesis. As a result, people
 with NF1 are at increased risk for the development of nervous and non-nervous system malignancies. Malignancy is a major source
 of morbidity and mortality in NF1. The natural history of NF1-associated malignancies is often different than that of their
 sporadic counterparts and, as such, management strategies need to be adjusted accordin...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2330152</comments>
            <pubDate>Sun, 05 Apr 2009 13:13:02 +0100</pubDate>
            <guid isPermaLink="false">2330152</guid>        </item>
        <item>
            <title>Is 
 GIGYF2
 the defective gene at the PARK11 locus?</title>
            <link>http://www.medworm.com/index.php?rid=2330151&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F8282747061954046%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The number of genes and loci for Parkinson’s disease was expanded during 2008. Among the most interesting findings of the
 year was the nomination of GIGYF2 as the gene that is defective at the PARK11 locus and is a potentially frequent cause of typical Parkinson’s disease. However,
 the optimism generated by the initial report has quickly been tempered by results obtained in the first wave of follow-up
 studies.
 
	Content Type Journal ArticleDOI 10.1007/s11910-009-0028-3Authors
		Vincenzo Bonifati, Erasmus Medical Center Department of Clinical Genetics Box 2040 3000 CA Rotterdam The Netherlands
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 3 / May, 2...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2330151</comments>
            <pubDate>Sun, 05 Apr 2009 13:13:02 +0100</pubDate>
            <guid isPermaLink="false">2330151</guid>        </item>
        <item>
            <title>Gross total resection of low-grade glioma in adults</title>
            <link>http://www.medworm.com/index.php?rid=2330153&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff0734nhg824u7q39%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trials ReportDOI 10.1007/s11910-009-0027-4Authors
		Lauren E. Abrey
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 3 / May, 2009 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2330153</comments>
            <pubDate>Sun, 05 Apr 2009 13:13:01 +0100</pubDate>
            <guid isPermaLink="false">2330153</guid>        </item>
        <item>
            <title>Pseudoprogression and pseudoresponse: Challenges in brain tumor imaging</title>
            <link>http://www.medworm.com/index.php?rid=2330154&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F740874jmx0756518%2F</link>
            <description>This article reviews the challenges of brain tumor imaging and its use in assessment of
 treatment response.
 
	Content Type Journal ArticleDOI 10.1007/s11910-009-0035-4Authors
		Jennifer L. Clarke, University of California-San Francisco Department of Neurological Surgery, Division of Neuro-oncology 400 Parnassus Avenue, A-808 Box 0372 San Francisco CA 94143 USASusan Chang
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 3 / May, 2009 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2330154</comments>
            <pubDate>Sun, 05 Apr 2009 13:13:00 +0100</pubDate>
            <guid isPermaLink="false">2330154</guid>        </item>
        <item>
            <title>Management of brain metastases</title>
            <link>http://www.medworm.com/index.php?rid=2330156&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F6406189026540531%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Brain metastases represent a common and devastating complication of cancer. With advances in surgery, radiology, and medical
 and radiation oncology, the number of treatment options have greatly increased. In addition, the prognosis for patients can
 vary widely depending on factors such as the number of lesions, extent of extracranial disease, age, and functional status.
 Recently, the possible impairment of whole brain radiation therapy on neurocognitive function has been a subject of concern
 and debate. Thus, the use of whole brain radiation therapy in conjunction with other treatment modalities should be optimized
 to ensure the best outcomes with regard to tumor control and functional status. As a result, patient management has become
 controversial, with strong o...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2330156</comments>
            <pubDate>Sun, 05 Apr 2009 13:12:59 +0100</pubDate>
            <guid isPermaLink="false">2330156</guid>        </item>
        <item>
            <title>Advances in meningioma therapy</title>
            <link>http://www.medworm.com/index.php?rid=2330155&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe224074867u75588%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Meningiomas are the most common primary brain tumors in adults. Most of them are benign (World Health Organization [WHO] grade
 I), slow-growing lesions, but some are classified as atypical (WHO grade II) or malignant (WHO grade III). Surgical resection
 is curative when complete removal of a benign meningioma is possible. Incompletely resected tumors and high-grade lesions
 are frequently treated with fractionated radiotherapy or stereotactic radiosurgery. Radiotherapy effectively reduces recurrence
 rates with limited toxicity. High-grade meningiomas tend to recur following maximal treatment with surgery and radiation.
 Chemotherapeutic agents, including hydroxyurea, have been used for recurrent disease with marginal efficacy. As the molecular
 pathogenesis of meningi...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2330155</comments>
            <pubDate>Sun, 05 Apr 2009 13:12:59 +0100</pubDate>
            <guid isPermaLink="false">2330155</guid>        </item>
        <item>
            <title>Mitochondrial dynamics and neurodegeneration</title>
            <link>http://www.medworm.com/index.php?rid=2330157&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F50l3410746351305%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Mitochondria are key organelles in eukaryotic cells that not only generate adenosine triphosphate but also perform such critical
 functions as hosting essential biosynthetic pathways, calcium buffering, and apoptotic signaling. In vivo, mitochondria form
 dynamic networks that undergo frequent morphologic changes through fission and fusion. In neurons, the imbalance of mitochondrial
 fission/fusion can influence neuronal physiology, such as synaptic transmission and plasticity, and affect neuronal survival.
 Core components of the mitochondrial fission/fusion machinery have been identified through genetic studies in model organisms.
 Mutations in some of these genes in humans have been linked to rare neurodegenerative diseases such as Charcot-Marie-Tooth
 subtype 2A and...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2330157</comments>
            <pubDate>Sun, 05 Apr 2009 13:12:58 +0100</pubDate>
            <guid isPermaLink="false">2330157</guid>        </item>
        <item>
            <title>Recent advances in the genetics of amyotrophic lateral sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=2330159&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F47152l146850n242%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disorder with a low survival rate beyond 5 years from
 symptom onset. Although the genes that cause most cases of ALS are still unknown, several important genetic discoveries have
 been made recently that will bring substantial insight into some of the mechanisms involved in ALS. Mutations in two genes
 with related functions were recently reported in patients with familial ALS: the FUS/TLS gene at the ALS6 locus on chromosome 16 and the TARDBP gene at the ALS10 locus on chromosome 1. In addition, the first wave of genomewide association studies in ALS has been published. While these
 studies clearly show that there is no definitive and common highly penetrant allele that causes ALS, some interesting...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2330159</comments>
            <pubDate>Sun, 05 Apr 2009 13:12:57 +0100</pubDate>
            <guid isPermaLink="false">2330159</guid>        </item>
        <item>
            <title>Genetics of paroxysmal dyskinesias</title>
            <link>http://www.medworm.com/index.php?rid=2330158&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv702725217307364%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Paroxysmal dyskinesias (PDs) are a heterogeneous group of disorders characterized by sudden attacks of involuntary movements
 that are mostly a combination of dystonia, chorea, athetosis, and ballism. They can sometimes be symptomatic, but usually
 an underlying cerebral lesion is not present. Most PDs have a genetic background and are divided into kinesigenic, nonkinesigenic,
 and exercise-induced forms. Recently, the first genes have been identified for paroxysmal nonkinesigenic dyskinesia (MR1) and paroxysmal exercise-induced dyskinesia (PED) (SLC2A1). Whereas the function of the MR-1 protein and the pathophysiology are still poorly understood, mutations in SLC2A1 and their functional characterization predict a reduced transport of glucose across the blood-brain barr...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2330158</comments>
            <pubDate>Sun, 05 Apr 2009 13:12:57 +0100</pubDate>
            <guid isPermaLink="false">2330158</guid>        </item>
        <item>
            <title>Genetics of autism spectrum disorders</title>
            <link>http://www.medworm.com/index.php?rid=2330160&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk03793763v886316%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Autism spectrum disorders (ASDs) are a clinically complex group of childhood disorders that have firm evidence of an underlying
 genetic etiology. Many techniques have been used to characterize the genetic bases of ASDs. Linkage studies have identified
 several replicated susceptibility loci, including 2q24–2q31, 7q, and 17q11–17q21. Association studies and mutation analysis
 of candidate genes have implicated the synaptic genes NRXN1, NLGN3, NLGN4, SHANK3, and CNTNAP2 in ASDs. Traditional cytogenetic approaches highlight the high frequency of large chromosomal abnormalities (3%–7% of patients),
 including the most frequently observed maternal 15q11–13 duplications (1%–3% of patients). Newly developed techniques include
 high-resolution DNA microarray technolo...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2330160</comments>
            <pubDate>Sun, 05 Apr 2009 13:12:56 +0100</pubDate>
            <guid isPermaLink="false">2330160</guid>        </item>
        <item>
            <title>Anti-vascular endothelial growth factor therapy for malignant glioma</title>
            <link>http://www.medworm.com/index.php?rid=2330161&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb2j5h643280hm147%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Glioblastomas are among the most vascular tumors because they oversecrete vascular endothelial growth factor (VEGF), a potent
 stimulator of angiogenesis. Consequently, new drug regimens are being developed to target the VEGF signaling pathway in an
 attempt to halt tumor growth. Antibodies that bind VEGF, decoy molecules that sequester VEGF, and small molecule tyrosine
 kinase inhibitors that block receptor activation are being tested. Preliminary results with these agents have been promising,
 with prolonged progression-free survival reported. The antipermeability effects of anti-VEGF agents have important consequences
 for tumor imaging and for patient quality of life by decreasing corticosteroid dependence. However, because most patients
 eventually relapse, more wo...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2330161</comments>
            <pubDate>Sun, 05 Apr 2009 13:12:55 +0100</pubDate>
            <guid isPermaLink="false">2330161</guid>        </item>
        <item>
            <title>Reversible cerebral vasoconstriction syndrome: A thunderclap headache-associated condition</title>
            <link>http://www.medworm.com/index.php?rid=2261113&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg21850457764052u%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Reversible cerebral vasoconstriction syndrome (RCVS) is characterized by a sudden, severe headache at onset, vascular narrowing
 involving the circle of Willis and its immediate branches, and angiographic evidence of vasoconstriction reversibility within
 minutes to weeks of onset. RCVS is underrecognized and often misdiagnosed; it can defy clinical detection because it can mimic
 common conditions such as migraine and ischemic stroke. A lack of shared nosology has hampered awareness and understanding
 of the syndrome. Clinicians must consider primary angiitis of the central nervous system because of its high rates of morbidity
 and mortality if left untreated. RCVS has a number of primary and secondary associations (cerebral hemorrhage, vasoactive
 substances, the peri...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2261113</comments>
            <pubDate>Tue, 10 Mar 2009 08:11:32 +0100</pubDate>
            <guid isPermaLink="false">2261113</guid>        </item>
        <item>
            <title>Status epilepticus in children</title>
            <link>http://www.medworm.com/index.php?rid=2261112&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq35865q315x360x7%2F</link>
            <description>This article highlights the epidemiology of status epilepticus, both convulsive
 and nonconvulsive, in children. It also reviews the recommended medications for first-line treatment of status epilepticus
 and refractory status epilepticus. Emphasis is placed on future pharmacotherapies and consideration of neurosurgical intervention
 when indicated.
 
	Content Type Journal ArticleDOI 10.1007/s11910-009-0022-9Authors
		Rani K. SinghWilliam D. Gaillard, Children’s National Medical Center 111 Michigan Avenue NW Washington, DC 20010 USA
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 2 / March, 2009 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2261112</comments>
            <pubDate>Tue, 10 Mar 2009 08:11:32 +0100</pubDate>
            <guid isPermaLink="false">2261112</guid>        </item>
        <item>
            <title>Neurostimulation for primary headache disorders</title>
            <link>http://www.medworm.com/index.php?rid=2261114&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F065117245t237517%2F</link>
            <description>This article discusses the theorized mechanisms of action of
 these novel treatment modalities and summarizes current knowledge regarding safety and efficacy of neurostimulation for the
 treatment of headache.
 
	Content Type Journal ArticleDOI 10.1007/s11910-009-0017-6Authors
		Todd J. Schwedt, Washington University School of Medicine 660 South Euclid Avenue Campus Box 8111 St. Louis MO 63110 USA
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 2 / March, 2009 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2261114</comments>
            <pubDate>Tue, 10 Mar 2009 08:11:31 +0100</pubDate>
            <guid isPermaLink="false">2261114</guid>        </item>
        <item>
            <title>Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children</title>
            <link>http://www.medworm.com/index.php?rid=2261117&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx1347k7m06730v41%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trials ReportDOI 10.1007/s11910-009-0015-8Authors
		Roger J. Packer
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 2 / March, 2009 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2261117</comments>
            <pubDate>Tue, 10 Mar 2009 08:11:30 +0100</pubDate>
            <guid isPermaLink="false">2261117</guid>        </item>
        <item>
            <title>Snoring and carotid artery atherosclerosis</title>
            <link>http://www.medworm.com/index.php?rid=2261116&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7m86j00312228368%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trials ReportDOI 10.1007/s11910-009-0016-7Authors
		Michael Thorpy
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 2 / March, 2009 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2261116</comments>
            <pubDate>Tue, 10 Mar 2009 08:11:30 +0100</pubDate>
            <guid isPermaLink="false">2261116</guid>        </item>
        <item>
            <title>Motor cortex and deep brain stimulation for the treatment of intractable neuropathic face pain</title>
            <link>http://www.medworm.com/index.php?rid=2261115&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ffw38h3574l256056%2F</link>
            <description>This article reviews the current literature
 and practices regarding patient selection criteria, potential mechanisms of action, surgical technique, and outcome of patients
 with neuropathic face pain treated with MCS and DBS.
 
	Content Type Journal ArticleDOI 10.1007/s11910-009-0020-yAuthors
		Laneshia ThomasJonathan M. BledsoePaola SandroniDeborah GormanKendall H. Lee, Mayo Clinic Department of Neurosurgery 200 First Street SW Rochester MN 55905 USA
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 2 / March, 2009 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2261115</comments>
            <pubDate>Tue, 10 Mar 2009 08:11:30 +0100</pubDate>
            <guid isPermaLink="false">2261115</guid>        </item>
        <item>
            <title>An oral calcitonin gene-related peptide receptor antagonist for acute migraine management: Sign of a possible new chapter in headache medicine</title>
            <link>http://www.medworm.com/index.php?rid=2261118&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe01q02627q627347%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trials ReportDOI 10.1007/s11910-009-0014-9Authors
		Ivan Garza
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 2 / March, 2009 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2261118</comments>
            <pubDate>Tue, 10 Mar 2009 08:11:29 +0100</pubDate>
            <guid isPermaLink="false">2261118</guid>        </item>
        <item>
            <title>Medication overuse headache</title>
            <link>http://www.medworm.com/index.php?rid=2261119&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw60736233680362j%2F</link>
            <description>This article reviews the literature on the epidemiology, risk factors, and pathophysiology
 of MOH. It also summarizes current strategies for treating and preventing headache chronicity.
 
	Content Type Journal ArticleDOI 10.1007/s11910-009-0019-4Authors
		Zaza Katsarava, University of Duisburg-Essen Department of Neurology Hufelandstrasse 55 45147 Essen GermanyDagny HolleHans-Christoph Diener
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 2 / March, 2009 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2261119</comments>
            <pubDate>Tue, 10 Mar 2009 08:11:28 +0100</pubDate>
            <guid isPermaLink="false">2261119</guid>        </item>
        <item>
            <title>Neurometabolic disorders and dysfunction in autism spectrum disorders</title>
            <link>http://www.medworm.com/index.php?rid=2261120&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv45l00t1r38n8101%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The cause of autism remains largely unknown because it is likely multifactorial, arising from the interaction of biologic,
 genetic, and environmental factors. The specific role of metabolic abnormalities also is largely unknown, but current research
 may provide insight into the pathophysiologic underpinnings of autism, at least in some patients. We review a number of known
 neurometabolic disorders identified as having an autistic phenotype. We also discuss the possible involvement of mitochondrial
 disorders and dysfunction as well as a theory regarding an increased vulnerability to oxidative stress, by which various environmental
 toxins produce metabolic alterations that impair normal cellular function. Finally, we review various strategies for metabolic
 work-up a...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2261120</comments>
            <pubDate>Tue, 10 Mar 2009 08:11:26 +0100</pubDate>
            <guid isPermaLink="false">2261120</guid>        </item>
        <item>
            <title>Sleep apnea in pediatric neurological conditions</title>
            <link>http://www.medworm.com/index.php?rid=2261122&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk684n671j766721x%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Sleep apnea in neurologically compromised children is common but underrecognized. It can be secondary to diseases at all locations
 on the neuroaxis and may independently alter their presentation, severity, and course. As a primary and secondary illness,
 it is associated with significant neurological morbidities. In its severe manifestation, it can cause life-threatening short-
 and long-term systemic morbidities. The authors review the most recent and relevant literature and provide the pediatric neurologist
 with a framework with which to identify children at risk.
 
	Content Type Journal ArticleDOI 10.1007/s11910-009-0023-8Authors
		Gabor Szuhay, George Washington University of Medicine, Children’s National Medical Center Department of Neurosciences and Behavioral...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2261122</comments>
            <pubDate>Tue, 10 Mar 2009 08:11:25 +0100</pubDate>
            <guid isPermaLink="false">2261122</guid>        </item>
        <item>
            <title>Neurobehavioral, health, and safety consequences associated with shift work in safety-sensitive professions</title>
            <link>http://www.medworm.com/index.php?rid=2261121&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F498w008533600u68%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Almost 15% of the full-time workers in the United States are shift workers. We review the physiologic challenges inherent
 not only in traditional night or rotating shifts but also in extended-duration shifts and other nonstandard hours. The challenging
 schedules of those in particularly safety-sensitive professions such as police officers, firefighters, and health care providers
 are highlighted. Recent findings describing the neurobehavioral, health, and safety outcomes associated with shift work also
 are reviewed. Comprehensive fatigue management programs that include education, screening for common sleep disorders, and
 appropriate interventions need to be developed to minimize these negative consequences associated with shift work.
 
	Content Type Journal Article...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2261121</comments>
            <pubDate>Tue, 10 Mar 2009 08:11:25 +0100</pubDate>
            <guid isPermaLink="false">2261121</guid>        </item>
        <item>
            <title>Sleep and menopause</title>
            <link>http://www.medworm.com/index.php?rid=2261124&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj31068776377p3r6%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Understanding sleep complaints of menopausal women is an emerging area of clinical and research interest. In this article,
 we summarize the most relevant and recent literature to provide an update on sleep in perimenopause and postmenopause. Our
 discussion includes the causes, clinical diagnosis, and treatment of sleep disorders in perimenopausal and postmenopausal
 women.
 
	Content Type Journal ArticleDOI 10.1007/s11910-009-0025-6Authors
		Sara Nowakowski, University of California San Diego Department of Psychiatry 9500 Gilman Drive La Jolla CA 92093 USACharles J. MeliskaL. Fernando MartinezBarbara L. Parry
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2261124</comments>
            <pubDate>Tue, 10 Mar 2009 08:11:24 +0100</pubDate>
            <guid isPermaLink="false">2261124</guid>        </item>
        <item>
            <title>Sleep disorders and daytime sleepiness in Parkinson’s disease</title>
            <link>http://www.medworm.com/index.php?rid=2261123&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ftk0v884212210v38%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Patients with Parkinson’s disease commonly have sleep disturbances that significantly alter quality of life but are often
 underrecognized. Awareness of the importance of these sleep disorders has been growing, and more research is being conducted.
 Patients with Parkinson’s disease have difficulties that not only include falling asleep and staying asleep but also include
 excessive daytime sleepiness and abnormal events during sleep. These sleep disturbances are often multifactorial in nature,
 resulting from degeneration of the cortical sleep centers to effects of medications taken to treat the motor symptoms associated
 with Parkinson’s disease. A thorough evaluation should be performed to assess for the presence of sleep disturbances and daytime
 sleepiness. M...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2261123</comments>
            <pubDate>Tue, 10 Mar 2009 08:11:24 +0100</pubDate>
            <guid isPermaLink="false">2261123</guid>        </item>
        <item>
            <title>Treatment of unruptured intracranial aneurysms: Surgery, coiling, or nothing?</title>
            <link>http://www.medworm.com/index.php?rid=2047655&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff533u0884265244w%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The decision of whether and how to treat an unruptured intracranial aneurysm (UIA) is complex. The goal in caring for patients
 with UIAs is to maximize their duration of high-quality life by optimally balancing the risks of aneurysm rupture—the “natural
 history” of the aneurysm—with those of treatment-related adverse outcomes. In this article, we review the literature concerning
 the natural history of UIAs and summarize the procedure-associated morbidity and mortality and efficacy of surgical clipping
 and endovascular coiling. Using this information, we make recommendations regarding the optimal management of patients with
 UIAs.
 
	Content Type Journal ArticleDOI 10.1007/s11910-009-0002-0Authors
		Joseph D. BurnsRobert D. Brown, Mayo Clinic Department of Ne...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2047655</comments>
            <pubDate>Tue, 16 Dec 2008 08:41:32 +0100</pubDate>
            <guid isPermaLink="false">2047655</guid>        </item>
        <item>
            <title>Extending the time frame for emergency intravenous thrombolytic therapy for treatment of acute ischemic stroke</title>
            <link>http://www.medworm.com/index.php?rid=2047654&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F0g3n2743t48570l7%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trials ReportDOI 10.1007/s11910-009-0001-1Authors
		Harold P. Adams
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 1 / January, 2009 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2047654</comments>
            <pubDate>Tue, 16 Dec 2008 08:41:32 +0100</pubDate>
            <guid isPermaLink="false">2047654</guid>        </item>
        <item>
            <title>Treatment of intracerebral hemorrhage: What should we do now?</title>
            <link>http://www.medworm.com/index.php?rid=2047653&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F0q86661067804nq4%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Intracerebral hemorrhage (ICH) is the most lethal type of stroke. Level I, class A evidence of effective treatment is lacking.
 Many issues surrounding the optimal management of ICH, such as blood pressure control, prevention of hematoma growth, containing
 brain edema, and preserving cerebral perfusion, need more rigorous clinical research. However, when selected appropriately,
 the mortality of certain patients with ICH may improve when treated early with minimally invasive neurosurgery or perhaps
 intravenous hemostatics. In addition, patients with ICHs may have better outcome when medical care is optimized according
 to the published ICH treatment guidelines. Stem cell therapy has shown promise for better functional recovery.
 
	Content Type Journal ArticleDOI 10.10...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2047653</comments>
            <pubDate>Tue, 16 Dec 2008 08:41:32 +0100</pubDate>
            <guid isPermaLink="false">2047653</guid>        </item>
        <item>
            <title>Genetics of ischemic stroke: Inheritance of a sporadic disorder</title>
            <link>http://www.medworm.com/index.php?rid=2047652&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq66261716887v386%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Stroke is a common neurologic disorder associated with comorbidities such as obesity, hypertension, hypercholesterolemia,
 and diabetes mellitus. Smoking or being the first-degree relative of a stroke patient can independently almost double the
 risk of ischemic stroke, supporting the hypothesis that stroke results from an intricate interplay between genes and the environment.
 Several candidate genes have been nominated but not confirmed as influencing stroke susceptibility and phenotype. A number
 of genes involved in monogenic forms of disease have been identified as causative in familial stroke. Herein we discuss these
 genes and the potential role of genetics in the more common sporadic form of stroke and therapeutic intervention strategies.
 
	Content Type Journal...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2047652</comments>
            <pubDate>Tue, 16 Dec 2008 08:41:32 +0100</pubDate>
            <guid isPermaLink="false">2047652</guid>        </item>
        <item>
            <title>The interface between stroke and infectious disease: Infectious diseases leading to stroke and infections complicating stroke</title>
            <link>http://www.medworm.com/index.php?rid=2047651&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F91uhu28808536u01%2F</link>
            <description>This article summarizes current clinical and experimental data regarding the interactions
 between stroke and infection and outlines possible targets for therapeutic intervention.
 
	Content Type Journal ArticleDOI 10.1007/s11910-009-0005-xAuthors
		Georgios ManousakisMatthew B. Jensen, University of Wisconsin School of Medicine and Public Health, H6/574 Clinical Sciences Center Department of Neurology 600 Highland Avenue Madison WI 53792 USAMarcus R. ChaconJustin A. SattinRoss L. Levine
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 1 / January, 2009 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2047651</comments>
            <pubDate>Tue, 16 Dec 2008 08:41:32 +0100</pubDate>
            <guid isPermaLink="false">2047651</guid>        </item>
        <item>
            <title>Advances in transcranial doppler ultrasonography</title>
            <link>http://www.medworm.com/index.php?rid=2047659&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd18jr36p752gq1k3%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Transcranial Doppler ultrasonography (TCD) is the only noninvasive real-time neuroimaging modality for the evaluation of characteristics
 of blood flow in basal intracerebral vessels that adds physiologic information to structural imaging. TCD has been rapidly
 evolving from a simple noninvasive diagnostic tool to an imaging modality with a broad spectrum of clinical applications.
 In acute stroke, TCD can provide rapid information about vascular stenosis and occlusion, the hemodynamic status of the cerebral
 circulation, and real-time monitoring of recanalization. Extended applications such as vasomotor reactivity testing, emboli
 monitoring, and right-to-left shunt detection help clinicians ascertain stroke mechanisms at the bedside, plan and monitor
 treatment, and d...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2047659</comments>
            <pubDate>Tue, 16 Dec 2008 08:41:31 +0100</pubDate>
            <guid isPermaLink="false">2047659</guid>        </item>
        <item>
            <title>Two strikes against mycophenolate mofetil therapy for myasthenia gravis</title>
            <link>http://www.medworm.com/index.php?rid=2047658&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fwj559vwj1r2n67l0%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trials ReportDOI 10.1007/s11910-009-0009-6Authors
		Michio Hirano
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 1 / January, 2009 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2047658</comments>
            <pubDate>Tue, 16 Dec 2008 08:41:31 +0100</pubDate>
            <guid isPermaLink="false">2047658</guid>        </item>
        <item>
            <title>Update on medication-induced peripheral neuropathy</title>
            <link>http://www.medworm.com/index.php?rid=2047657&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe06m367107290223%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Despite improvements in the identification of causes of peripheral neuropathy, idiopathic polyneuropathy remains common. Medication
 and toxic neuropathy account for a small but important percentage of potentially preventable or reversible causes of neuropathy.
 New drugs that can induce neuropathy have been approved over the past several years, including the anticancer agents bortezomib,
 ixabepilone, and oxaliplatin. We review the neurotoxic effects of tumor necrosis factor-α blockers infliximab and etanercept,
 the inflammatory arthritis agent leflunomide, and the antibiotic linezolid. The controversy of statin-induced neuropathy continues
 to unfold; the large Fremantle Diabetes Study has suggested that statins may have neuroprotective effects. Dichloroacetate
 is ...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2047657</comments>
            <pubDate>Tue, 16 Dec 2008 08:41:31 +0100</pubDate>
            <guid isPermaLink="false">2047657</guid>        </item>
        <item>
            <title>Development of an emergency department response to acute stroke (“Code stroke”)</title>
            <link>http://www.medworm.com/index.php?rid=2047656&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx346x68167t3u1k6%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Minimizing delays is a crucial step in improving outcomes with acute stroke therapies whose efficacy is clearly time dependent.
 Logistic and human barriers to rapid stroke care can be overcome with a systematic “Code Stroke” approach provided by a structured
 multidisciplinary acute stroke response team. Such teams should include Emergency Medical Services providers, neurologists,
 neurosurgeons, diagnostic radiologists, nurses, radiology technicians, laboratory personnel, hospital administrators, and
 emergency medicine, intensive care, and neurointerventional physicians. An acute stroke team improves treatment practices
 and provides a gratifying experience for patients, families, and referring physicians. On the other hand, maintaining proficiency
 of the team...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2047656</comments>
            <pubDate>Tue, 16 Dec 2008 08:41:31 +0100</pubDate>
            <guid isPermaLink="false">2047656</guid>        </item>
        <item>
            <title>Inclusion body myositis: Review of recent literature</title>
            <link>http://www.medworm.com/index.php?rid=2047663&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu013kkkm521wxj62%2F</link>
            <description>This article discusses existing literature, emphasizing disease mechanisms and models. In particular, it addresses
 limitations in the β-amyloid-mediated theory of IBM myofiber injury, flawed rationales of animal models of this disease, and
 recent reports regarding treatment.
 
	Content Type Journal ArticleDOI 10.1007/s11910-009-0013-xAuthors
		Steven A. Greenberg, Brigham and Women’s Hospital Department of Neurology 75 Francis Street Boston MA 02115 USA
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 1 / January, 2009 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2047663</comments>
            <pubDate>Tue, 16 Dec 2008 08:41:30 +0100</pubDate>
            <guid isPermaLink="false">2047663</guid>        </item>
        <item>
            <title>Oculopharyngeal muscular dystrophy: A polyalanine myopathy</title>
            <link>http://www.medworm.com/index.php?rid=2047662&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4253051t422h512n%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;It has been 10 years since the identification of the first PABPN1 gene (GCN)n/polyalanine mutations responsible for oculopharyngeal muscular dystrophy (OPMD). These mutations have been found in most
 cases of OPMD diagnosed in more than 35 countries. Sequence analyses have shown that such mutations have occurred numerous
 times in human history. Although PABPN1 was found early on to be a component of the classic filamentous intranuclear inclusions
 (INIs), mRNA and other proteins also have been found to coaggregate in the INIs. It is still unclear if the INIs play a pathologic
 or a protective role. The generation of numerous cell and animal models of OPMD has led to greater insight into its complex
 molecular pathophysiology and identified the first candidate therapeut...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2047662</comments>
            <pubDate>Tue, 16 Dec 2008 08:41:30 +0100</pubDate>
            <guid isPermaLink="false">2047662</guid>        </item>
        <item>
            <title>Amyotrophic lateral sclerosis: Clinical management and research update</title>
            <link>http://www.medworm.com/index.php?rid=2047661&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc21771l713201811%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that selectively affects the motor neurons
 of the brain and spinal cord. ALS occurs in about 1 in 100,000 individuals. Although recent advances have been made in understanding
 the pathogenesis of ALS, there has been no new effective pharmacotherapy since the approval of riluzole more than 10 years
 ago. The mainstay of clinical management includes pharmacologic management of symptoms, management of dysphagia and respiratory
 symptoms, palliative care, and multidisciplinary care clinics. In this review, we discuss the clinical management of ALS,
 recent modifications to the diagnostic criteria, and current clinical trials.
 
	Content Type Journal ArticleDOI 10.1007/s11910-009-0010-0Authors
	...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2047661</comments>
            <pubDate>Tue, 16 Dec 2008 08:41:30 +0100</pubDate>
            <guid isPermaLink="false">2047661</guid>        </item>
        <item>
            <title>Maximizing recovery from stroke: New advances in rehabilitation</title>
            <link>http://www.medworm.com/index.php?rid=2047660&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv45520838582016x%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Stroke is the leading cause of disability in the United States. The magnitude of its economic impact is growing due to improved
 survival and the aging of the population. Acute interventions for stroke have had little effect on cost. Functional neuroimaging
 and transcutaneous magnetic stimulation have enhanced our understanding of how the brain reorganizes during recovery and in
 response to rehabilitation. Cell transplantation combined with growth factors holds promise for the future. Restorative approaches
 involving repetitive practice are emerging as effective techniques in improving post-stroke function. Clinical adoption remains
 slow due to time and funding constraints. Health policy changes are needed that focus funding and research efforts on stroke
 recovery....</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2047660</comments>
            <pubDate>Tue, 16 Dec 2008 08:41:30 +0100</pubDate>
            <guid isPermaLink="false">2047660</guid>        </item>
        <item>
            <title>Variability in recovery from aphasia</title>
            <link>http://www.medworm.com/index.php?rid=1985224&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4k47531kq372x5r7%2F</link>
            <description>This article provides a review of aphasia-recovery research and a framework for approaching the
 variability of recovery in clinical practice.
 
	Content Type Journal ArticleDOI 10.1007/s11910-008-0079-xAuthors
		Ronald M. Lazar, Columbia University Medical Center Levine Cerebral Localization Laboratory, Division of Stroke and Critical Care 710 West 168th Street New York NY 10032 USADaniel Antoniello
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 8
	
		Journal Issue Volume 8, Number 6 / November, 2008 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1985224</comments>
            <pubDate>Sun, 23 Nov 2008 06:50:12 +0100</pubDate>
            <guid isPermaLink="false">1985224</guid>        </item>
        <item>
            <title>Web alert</title>
            <link>http://www.medworm.com/index.php?rid=1985228&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F23789251664322gq%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s11910-008-0071-5

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 8
	
		Journal Issue Volume 8, Number 6 / November, 2008 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1985228</comments>
            <pubDate>Sun, 23 Nov 2008 06:50:11 +0100</pubDate>
            <guid isPermaLink="false">1985228</guid>        </item>
        <item>
            <title>Effectiveness of inactivated poliovirus vaccine</title>
            <link>http://www.medworm.com/index.php?rid=1985227&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj91643358j536525%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trials ReportDOI 10.1007/s11910-008-0072-4Authors
		Burk Jubelt
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 8
	
		Journal Issue Volume 8, Number 6 / November, 2008 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1985227</comments>
            <pubDate>Sun, 23 Nov 2008 06:50:11 +0100</pubDate>
            <guid isPermaLink="false">1985227</guid>        </item>
        <item>
            <title>HIV-associated neurocognitive disorders and the impact of combination antiretroviral therapies</title>
            <link>http://www.medworm.com/index.php?rid=1985226&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F37r1354038j54014%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;HIV-associated neurocognitive disorders (HAND) are the most common preventable and treatable cause of dementia. While the
 incidence of the most severe form of HAND, HIV-associated dementia, has decreased since the introduction of combination antiretroviral
 therapy (cART), the prevalence of less severe forms of HAND has continued to rise. HAND leads to a subcortical dementia consisting
 of a triad of cognitive, behavior, and motor dysfunction. No single laboratory test can establish HAND, but ancillary studies
 including neuropsychological testing, neuroimaging studies, and cerebrospinal fluid (CSF) analysis are useful for supporting
 or refuting the diagnosis. More recent evidence has suggested that higher central nervous system-penetrating cART may lead
 to greater s...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1985226</comments>
            <pubDate>Sun, 23 Nov 2008 06:50:11 +0100</pubDate>
            <guid isPermaLink="false">1985226</guid>        </item>
        <item>
            <title>Controversies in behavioral neurology: The use of atypical antipsychotic drugs to treat neurobehavioral symptoms in dementia</title>
            <link>http://www.medworm.com/index.php?rid=1985225&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk663601265u41775%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Abstract“Atypical” antipsychotic drugs are widely used in patients with neurobehavioral disturbances related to dementia.
 Recent reports have highlighted the risks of these agents, including increased mortality, and the US Food and Drug Administration
 (FDA) has issued black-box warnings concerning their use. Studies of efficacy have shown only limited evidence that these
 drugs are more effective than placebo in controlling abnormal behaviors or improving the lives of patients with dementia and
 their caregivers. Recent evidence suggests that the older, “typical” antipsychotic drugs have at least as much risk as the
 atypical agents, and FDA warnings have been extended to these agents. In managing the behavioral disturbances of demented
 patients, clinicians m...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1985225</comments>
            <pubDate>Sun, 23 Nov 2008 06:50:11 +0100</pubDate>
            <guid isPermaLink="false">1985225</guid>        </item>
        <item>
            <title>Critical care management of subarachnoid hemorrhage</title>
            <link>http://www.medworm.com/index.php?rid=1985232&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F0816733667v61144%2F</link>
            <description>This article
 reviews the natural history of aneurysmal subarachnoid hemorrhage and strategies for disease management in the acute setting.
 Available tools for monitoring brain function are discussed.
 
	Content Type Journal ArticleDOI 10.1007/s11910-008-0082-2Authors
		Joshua M. Levine, Hospital of the University of Pennsylvania Neurocritical Care Program 3 West Gates Building, 3400 Spruce Street Philadelphia PA 19103 USA
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 8
	
		Journal Issue Volume 8, Number 6 / November, 2008 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1985232</comments>
            <pubDate>Sun, 23 Nov 2008 06:50:10 +0100</pubDate>
            <guid isPermaLink="false">1985232</guid>        </item>
        <item>
            <title>Hemicraniectomy for middle cerebral artery infarction</title>
            <link>http://www.medworm.com/index.php?rid=1985231&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fgp3765u027g33257%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The space-occupying so-called “malignant” middle cerebral artery infarction is—besides acute basilar artery occlusion—the
 most devastating form of ischemic stroke. Until recently, there was no proven treatment. In 2007, results from randomized
 controlled trials provided evidence for the benefit of early hemicraniectomy with respect to mortality after 3 months. This
 review focuses on current treatment options for malignant ischemic brain infarction, especially hemicraniectomy. Moreover,
 major unsolved problems and open questions regarding the disease are discussed, and perspective is given on future clinical
 studies.
 
	Content Type Journal ArticleDOI 10.1007/s11910-008-0083-1Authors
		Hagen B. HuttnerEric JüttlerStefan Schwab, University of Erlangen Depart...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1985231</comments>
            <pubDate>Sun, 23 Nov 2008 06:50:10 +0100</pubDate>
            <guid isPermaLink="false">1985231</guid>        </item>
        <item>
            <title>Neuroimaging of disorders leading to dementia</title>
            <link>http://www.medworm.com/index.php?rid=1985230&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F1472718043232463%2F</link>
            <description>Content Type Journal ArticleCategory Invited CommentaryDOI 10.1007/s11910-008-0069-zAuthors
		Joseph C. Masdeu, Intramural Research Program Section on Integrative Neuroimaging, National Institutes of Health (NIH/NIMH-CBDB) 9000 Rockville Pike, Building 10, Room 4C101 Bethesda MD 20892 USABelen Pascual
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 8
	
		Journal Issue Volume 8, Number 6 / November, 2008 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1985230</comments>
            <pubDate>Sun, 23 Nov 2008 06:50:10 +0100</pubDate>
            <guid isPermaLink="false">1985230</guid>        </item>
        <item>
            <title>The CNS as a therapeutic target in multiple sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=1985229&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh820x37q83143j78%2F</link>
            <description>Content Type Journal ArticleCategory Invited CommentaryDOI 10.1007/s11910-008-0070-6Authors
		Jack P. Antel, McGill University Montreal Neurological Institute 3801 University Street, Room 111 Montreal QC H3A 2B4 Canada
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 8
	
		Journal Issue Volume 8, Number 6 / November, 2008 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1985229</comments>
            <pubDate>Sun, 23 Nov 2008 06:50:10 +0100</pubDate>
            <guid isPermaLink="false">1985229</guid>        </item>
        <item>
            <title>Neuroimaging and recovery of language in aphasia</title>
            <link>http://www.medworm.com/index.php?rid=1985237&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fwx87427u3m636339%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The use of functional neuroimaging techniques has advanced what is known about the neural mechanisms used to support language
 processing in aphasia resulting from brain damage. This paper highlights recent findings derived from neuroimaging studies
 focused on neuroplasticity of language networks, the role of the left and right hemispheres in this process, and studies examining
 how treatment affects the neurobiology of recovery. We point out variability across studies as well as factors related to
 this variability, and we emphasize challenges that remain for research.
 
	Content Type Journal ArticleDOI 10.1007/s11910-008-0076-0Authors
		Cynthia K. Thompson, Northwestern University 2240 Campus Drive Evanston IL 60208 USADirk-Bart den Ouden
	

	
		Journal Current Neuro...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1985237</comments>
            <pubDate>Sun, 23 Nov 2008 06:50:09 +0100</pubDate>
            <guid isPermaLink="false">1985237</guid>        </item>
        <item>
            <title>Update on adult attention-deficit/hyperactivity disorder</title>
            <link>http://www.medworm.com/index.php?rid=1985236&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw378l616g2275018%2F</link>
            <description>This article discusses the clinical assessment of adult ADHD, reviews
 the results of recent adult ADHD treatment studies with an emphasis on medications currently approved by the US Food and Drug
 Administration, and discusses the clinical management and monitoring of ADHD pharmacotherapy.
 
	Content Type Journal ArticleDOI 10.1007/s11910-008-0077-zAuthors
		Paul Hammerness, Clinical and Research Program in Pediatric Psychopharmacology 185 Alewife Brook Parkway, Suite 2000 Cambridge MA 02138 USACraig SurmanKatherine Miller
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 8
	
		Journal Issue Volume 8, Number 6 / November, 2008 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1985236</comments>
            <pubDate>Sun, 23 Nov 2008 06:50:09 +0100</pubDate>
            <guid isPermaLink="false">1985236</guid>        </item>
        <item>
            <title>Update on apraxia</title>
            <link>http://www.medworm.com/index.php?rid=1985235&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn1k16782l08r302w%2F</link>
            <description>We present several prominent models of praxis
 to explain the variety of difficulties seen in patients with apraxia. We also discuss the large-scale frontal-parietal-basal
 ganglia network thought to underlie praxis. In this context, we highlight the common occurrence of limb apraxia in corticobasal
 degeneration, a neurodegenerative condition characterized by frontal, parietal, and basal ganglia disease.
 
	Content Type Journal ArticleDOI 10.1007/s11910-008-0078-yAuthors
		Rachel Goldmann GrossMurray Grossman, Hospital of the University of Pennsylvania Department of Neurology, 2 Gibson 3400 Spruce Street Philadelphia PA 19104 USA
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 8
	
		Journal Issue Volume 8, Number...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1985235</comments>
            <pubDate>Sun, 23 Nov 2008 06:50:09 +0100</pubDate>
            <guid isPermaLink="false">1985235</guid>        </item>
        <item>
            <title>Blood pressure reduction for acute intracerebral hemorrhage: How low can you go?</title>
            <link>http://www.medworm.com/index.php?rid=1985234&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7q2615j708x1004r%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trials ReportDOI 10.1007/s11910-008-0080-4Authors
		Viktor SzederStephan A. Mayer
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 8
	
		Journal Issue Volume 8, Number 6 / November, 2008 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1985234</comments>
            <pubDate>Sun, 23 Nov 2008 06:50:09 +0100</pubDate>
            <guid isPermaLink="false">1985234</guid>        </item>
        <item>
            <title>Therapeutic hypothermia for cardiac arrest: A practical approach</title>
            <link>http://www.medworm.com/index.php?rid=1985233&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp772603333540286%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Therapeutic hypothermia (TH), which prevents and ameliorates the cascade of secondary neurologic injury after the return of
 spontaneous circulation, is the most effective neuroprotective therapy for encephalopathic survivors of cardiac arrest. Acute
 management of patients with severe hypoxic-ischemic encephalopathy requires rapid and well-coordinated efforts involving emergency
 medicine, neurology, cardiology, critical care medicine, and palliative care. This effort is complex, and broad implementation
 of TH has been slow in the United States and Europe. This review summarizes recent developments in the practical application
 of TH, reviews the role of the neurologist, and suggests an algorithm for coordination of care of cardiac arrest survivors
 by physicians of d...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1985233</comments>
            <pubDate>Sun, 23 Nov 2008 06:50:09 +0100</pubDate>
            <guid isPermaLink="false">1985233</guid>        </item>
        <item>
            <title>Wound botulism from heroin skin popping</title>
            <link>http://www.medworm.com/index.php?rid=1985238&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fdq554706h5284745%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Following the introduction of black tar heroin mainly from Mexico in the 1980s, cases of wound botulism dramatically increased
 in the western United States. Contamination with spores of Clostridium botulinum of black tar heroin occurs along the distribution line. The heating of heroin powder to solubilize it for subcutaneous injection
 (“skin popping”) does not kill the spores. The spores germinate in an anaerobic tissue environment and release botulinum toxin
 type A or B. Unless skin abscesses are found in the patient, the clinical diagnosis is often challenging. Facilitation of
 the compound muscle action potential by repetitive nerve stimulation at 20 to 50 Hz is an important and rapid diagnostic test.
 Definite diagnosis is made by detection of botulinum toxin...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1985238</comments>
            <pubDate>Sun, 23 Nov 2008 06:50:08 +0100</pubDate>
            <guid isPermaLink="false">1985238</guid>        </item>
        <item>
            <title>Cavitary anomalies of the optic disc: Neurologic significance</title>
            <link>http://www.medworm.com/index.php?rid=1888488&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fblp03502728073r1%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Cavitary congenital optic disc anomalies include optic disc coloboma, morning glory disc anomaly, optic pit, and the papillorenal
 syndrome. Peripapillary staphyloma is occasionally included in this group but it does not represent an anomaly of the optic
 disc itself and is not discussed herein. A variety of systemic and neurologic conditions may accompany these optic disc anomalies.
 Precise classification can be difficult and some debate exists as to whether these anomalies represent distinct clinical entities
 or are part of a single spectrum of disease. This is further complicated by historical inconsistencies in the literature.
 Advances in molecular genetics may help to define clearly the etiology of these anomalies.
 
	Content Type Journal ArticleDOI 10.1007/s119...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1888488</comments>
            <pubDate>Fri, 17 Oct 2008 09:43:04 +0100</pubDate>
            <guid isPermaLink="false">1888488</guid>        </item>
        <item>
            <title>Monoclonal antibody treatments for multiple sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=1888487&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F414642733765x11r%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Monoclonal antibodies (MAbs) may have great potential as therapies for autoimmune diseases. Their development as treatments
 for multiple sclerosis (MS) is promising. Partially effective immunomodulatory therapies have been helpful for many MS patients;
 however, for patients failing these immunomodulatory treatments, MAbs are an important new treatment option. Currently, MAbs
 are approved by the US Food and Drug Administration for treatment of many conditions, including autoimmune diseases. Four
 MAbs that have been investigated as potential treatments for MS are reviewed in this article. Of these MAbs, natalizumab is
 approved for treatment of MS. The other three MAbs (alemtuzumab, rituximab, and daclizumab) are all promising therapies in
 development for treatment o...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1888487</comments>
            <pubDate>Fri, 17 Oct 2008 09:43:04 +0100</pubDate>
            <guid isPermaLink="false">1888487</guid>        </item>
        <item>
            <title>Driving and neurodegenerative diseases</title>
            <link>http://www.medworm.com/index.php?rid=1888490&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa9tv062m550hx4w1%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The proportion of elderly people in the general population is rising, resulting in greater numbers of drivers with neurodegenerative
 disorders such as Alzheimer’s disease and Parkinson’s disease. These neurodegenerative disorders impair cognition, visual
 perception, and motor function, leading to reduced driver fitness and greater crash risk. Yet neither medical diagnosis nor
 age alone is reliable enough to predict driver safety or crashes or to revoke the driving privileges of these individuals.
 Driving research utilizes tools such as questionnaires about driving habits and history, driving simulators, standardized
 road tests utilizing instrumented vehicles, and state driving records. Research challenges include outlining the evolution
 of driving safety, unde...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1888490</comments>
            <pubDate>Fri, 17 Oct 2008 09:43:03 +0100</pubDate>
            <guid isPermaLink="false">1888490</guid>        </item>
        <item>
            <title>The syndrome of optic nerve hypoplasia</title>
            <link>http://www.medworm.com/index.php?rid=1888489&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ftq43118w2k065737%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The congenital malformation known as optic nerve hypoplasia (ONH) has been recognized in the past 30 years as an epidemic
 cause of congenital blindness. It was believed to occur either as an isolated anomaly or as a component of the syndrome of
 septo-optic dysplasia, which has evolved to include midline brain malformations and hypopituitarism. Evidence now suggests
 that ONH infrequently occurs in isolation. Most afflicted children will have hypothalamic dysfunction and/or neurodevelopmental
 impairment, regardless of MRI findings or severity of ONH. Adverse outcomes can often be ameliorated with early intervention.
 Thus, the syndrome of ONH should be suspected in all infants with signs of hypothalamic dysfunction or vision impairment.
 
	Content Type Journal Article...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1888489</comments>
            <pubDate>Fri, 17 Oct 2008 09:43:03 +0100</pubDate>
            <guid isPermaLink="false">1888489</guid>        </item>
        <item>
            <title>Understanding hippocampal sclerosis in the elderly: Epidemiology, characterization, and diagnostic issues</title>
            <link>http://www.medworm.com/index.php?rid=1888492&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F921824038v708822%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Hippocampal sclerosis (HS) is a pathologic term used to describe severe loss of neurons and reactive gliosis without cystic
 cavitation in the CA1 sector of the hippocampus. In late life, HS is associated with hippocampal atrophy, severe amnesia,
 and slowly progressive dementia without clinical seizure activity. HS is difficult to distinguish clinically from Alzheimer’s
 disease and is often diagnosed postmortem. In autopsy series, HS may be found without significant other pathology (2%–4% of
 cases), but it occurs frequently in combination with other vascular and neurodegenerative disorders (12%–20% of cases). HS
 is found bilaterally in 50% of cases and unilaterally in 50% of cases, with similar predilection for the right versus left
 hemisphere. The pathogenes...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1888492</comments>
            <pubDate>Fri, 17 Oct 2008 09:43:02 +0100</pubDate>
            <guid isPermaLink="false">1888492</guid>        </item>
        <item>
            <title>Normal pressure hydrocephalus: Diagnosis and treatment</title>
            <link>http://www.medworm.com/index.php?rid=1888491&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr55r471815763587%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Normal pressure hydrocephalus (NPH) is a syndrome of gait dysfunction and enlarged cerebral ventricles in the absence of another
 cause. It is frequently accompanied by frontal and subcortical cognitive deficits and bladder detrusor overactivity. NPH is
 rare relative to other potential causes of these symptoms in the elderly, but timely diagnosis can lead to reversal of symptoms
 through ventricular shunting. There are many tests used to predict possible response to surgery, such as MRI of the brain,
 formalized neuropsychological and gait testing, large-volume lumbar puncture, and prolonged lumbar drainage, but no one test
 has been validated to rule out potential response to surgery.
 
	Content Type Journal ArticleDOI 10.1007/s11910-008-0058-2Authors
		David Shpreche...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1888491</comments>
            <pubDate>Fri, 17 Oct 2008 09:43:02 +0100</pubDate>
            <guid isPermaLink="false">1888491</guid>        </item>
        <item>
            <title>Web alert</title>
            <link>http://www.medworm.com/index.php?rid=1888494&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F8135146jp168774n%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s11910-008-0055-5

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 8
	
		Journal Issue Volume 8, Number 5 / September, 2008 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1888494</comments>
            <pubDate>Fri, 17 Oct 2008 09:43:01 +0100</pubDate>
            <guid isPermaLink="false">1888494</guid>        </item>
        <item>
            <title>Donepezil in patients with subcortical vascular cognitive impairment</title>
            <link>http://www.medworm.com/index.php?rid=1888493&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq511367510k77074%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trials ReportDOI 10.1007/s11910-008-0056-4Authors
		Karen Marder
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 8
	
		Journal Issue Volume 8, Number 5 / September, 2008 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1888493</comments>
            <pubDate>Fri, 17 Oct 2008 09:43:01 +0100</pubDate>
            <guid isPermaLink="false">1888493</guid>        </item>
        <item>
            <title>The neuronal sortilin-related receptor gene 
 SORL1
 and late-onset Alzheimer’s disease</title>
            <link>http://www.medworm.com/index.php?rid=1888496&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff71471551mjw7w10%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Recent studies indicate that two clusters of single nucleotide polymorphisms in the neuronal sortilin-related receptor gene
 (SORL1) are causally associated with late-onset Alzheimer’s disease (AD). At the cellular level, SORL1 is thought to be involved in intracellular trafficking of amyloid precursor protein. When this gene is suppressed, toxic
 amyloid β production is increased, and high levels of amyloid β are associated with a higher AD risk. Extending the cellular
 findings, gene expression studies show that SORL1 is differentially expressed in AD patients compared with controls. Furthermore, several genetic studies have identified allelic
 and haplotypic SORL1 variants associated with late-onset AD, and these variants confer small to modest risk of AD. Taken ...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1888496</comments>
            <pubDate>Fri, 17 Oct 2008 09:43:00 +0100</pubDate>
            <guid isPermaLink="false">1888496</guid>        </item>
        <item>
            <title>Novel therapeutic targets in neurodegenerative diseases: Lessons from amyotrophic lateral sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=1888495&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fyul628550h2j81l6%2F</link>
            <description>Content Type Journal ArticleCategory Invited CommentaryDOI 10.1007/s11910-008-0054-6Authors
		Stanley H. Appel, Methodist Neurological Institute Department of Neurology 6560 Fannin, Suite #802 Houston TX 77030 USADavid R. BeersJenny S. HenkelWeihua Zhao
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 8
	
		Journal Issue Volume 8, Number 5 / September, 2008 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1888495</comments>
            <pubDate>Fri, 17 Oct 2008 09:43:00 +0100</pubDate>
            <guid isPermaLink="false">1888495</guid>        </item>
        <item>
            <title>Neuromyelitis optica: Diagnosis, pathogenesis, and treatment</title>
            <link>http://www.medworm.com/index.php?rid=1888499&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw63kuj20527p581r%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Although the co-occurrence of myelitis and optic neuritis that characterizes neuromyelitis optica (NMO) was recognized over
 a century ago, distinguishing NMO from multiple sclerosis relied solely on clinical criteria until recently. The identification
 of a biomarker that has high specificity for NMO is clinically useful for distinguishing NMO from multiple sclerosis and identifying
 patients at high risk for recurrent myelitis and optic neuritis. That fact that the biomarker is an autoantibody that recognizes
 aquaporin 4 (AQP4), a water channel expressed on astrocyte podocytes, has substantially contributed to the hypothesis that
 NMO is a humorally mediated autoimmune disease. This review discusses the discovery of the NMO-IgG biomarker, the identification
 of AQP4 ...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1888499</comments>
            <pubDate>Fri, 17 Oct 2008 09:42:59 +0100</pubDate>
            <guid isPermaLink="false">1888499</guid>        </item>
        <item>
            <title>B-cell depletion with rituximab in relapsing-remitting multiple sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=1888498&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe551815765660w28%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trials ReportDOI 10.1007/s11910-008-0064-4Authors
		Dennis BourdetteVijayshree Yadav
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 8
	
		Journal Issue Volume 8, Number 5 / September, 2008 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1888498</comments>
            <pubDate>Fri, 17 Oct 2008 09:42:59 +0100</pubDate>
            <guid isPermaLink="false">1888498</guid>        </item>
        <item>
            <title>Drusen of the optic disc</title>
            <link>http://www.medworm.com/index.php?rid=1888497&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx5t32246260w8k5u%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Optic disc drusen are acellular calcific deposits occurring in small, crowded optic discs with abnormal vasculature. Evidence
 suggests axoplasmic transport alteration and axonal degeneration are involved in disc drusen formation. In affected patients,
 the number and size of disc drusen are highly variable, and the drusen may be visible near the disc surface or buried within
 the disc, causing them to appear as pseudopapilledema. B-scan echography is the most sensitive method for detecting disc drusen.
 Most patients with disc drusen are asymptomatic, but progressive visual field loss and vascular complications, including anterior
 ischemic optic neuropathy and choroidal neovascularization, may occur. Optic disc drusen have no established effective treatment.
 Diagnosi...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1888497</comments>
            <pubDate>Fri, 17 Oct 2008 09:42:59 +0100</pubDate>
            <guid isPermaLink="false">1888497</guid>        </item>
        <item>
            <title>Pediatric multiple sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=1888500&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd3111l246r824473%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Diagnosing multiple sclerosis (MS) in a child is challenging because of the limited diagnostic criteria and their overlap
 with acute disseminated encephalomyelitis. Pediatric-onset MS patients are more likely to be male, have seizures, and have
 brainstem and cerebellar symptoms than adults, and are less likely to have spinal cord symptoms than adults. They mostly experience
 a relapsing-remitting course. Their initial brain MRI shows more frequent involvement of the posterior fossa, less well-defined
 ovoid lesions, and more confluent lesions that decrease over time in patients with prepubertal onset, making early diagnosis
 even more difficult. Although disability progression is slower than in adults, pediatric onset MS leads to significant disability
 at a younger a...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1888500</comments>
            <pubDate>Fri, 17 Oct 2008 09:42:58 +0100</pubDate>
            <guid isPermaLink="false">1888500</guid>        </item>
        <item>
            <title>New molecular targets for antiepileptic drugs: α2δ, SV2A, and Kv7/KCNQ/M potassium channels</title>
            <link>http://www.medworm.com/index.php?rid=1886763&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fvp741172577x7j0x%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Many currently prescribed antiepileptic drugs (AEDs) act via voltage-gated sodium channels, through effects on γ-aminobutyric
 acid-mediated inhibition, or via voltage-gated calcium channels. Some newer AEDs do not act via these traditional mechanisms.
 The molecular targets for several of these nontraditional AEDs have been defined using cellular electrophysiology and molecular
 approaches. Here, we describe three of these targets: α2δ, auxiliary subunits of voltage-gated calcium channels through which the gabapentinoids gabapentin and pregabalin exert their
 anticonvulsant and analgesic actions; SV2A, a ubiquitous synaptic vesicle glycoprotein that may prepare vesicles for fusion
 and serves as the target for levetiracetam and its analog brivaracetam (which is curr...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1886763</comments>
            <pubDate>Thu, 16 Oct 2008 09:59:43 +0100</pubDate>
            <guid isPermaLink="false">1886763</guid>        </item>
        <item>
            <title>A single-blind trial of bilateral globus pallidus internus deep brain stimulation in medically refractory cervical dystonia</title>
            <link>http://www.medworm.com/index.php?rid=1886770&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh3386437u0240l40%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trials ReportDOI 10.1007/s11910-008-0043-9Authors
		John C. MorganKapil D. Sethi
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 8
	
		Journal Issue Volume 8, Number 4 / July, 2008 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1886770</comments>
            <pubDate>Thu, 16 Oct 2008 09:59:42 +0100</pubDate>
            <guid isPermaLink="false">1886770</guid>        </item>
        <item>
            <title>Memory and the brain: Beyond intracranial phrenology</title>
            <link>http://www.medworm.com/index.php?rid=1886769&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F951454x6rqw6w076%2F</link>
            <description>Content Type Journal ArticleCategory Invited CommentaryDOI 10.1007/s11910-008-0041-yAuthors
		David A. Drachman, University of Massachusetts Medical School Department of Neurology 55 Lake Avenue North Worcester MA 01655 USA
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 8
	
		Journal Issue Volume 8, Number 4 / July, 2008 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1886769</comments>
            <pubDate>Thu, 16 Oct 2008 09:59:42 +0100</pubDate>
            <guid isPermaLink="false">1886769</guid>        </item>
        <item>
            <title>Neuroprotection in Parkinson’s disease: Myth or reality?</title>
            <link>http://www.medworm.com/index.php?rid=1886768&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F20r097j70146kt22%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Parkinson’s disease (PD) is a chronic, progressive, neurodegenerative disorder with no cure. Therapies that delay or halt
 disease progression are urgently needed, but finding such therapies has been difficult. In this article, we review historical
 and recent clinical trial work in the field of neuroprotection. Several issues have arisen during the search for disease-modifying
 therapies, including challenges in selecting appropriate therapeutic targets, assessing potential therapies, and selecting
 the proper patient population to study. Advances in the understanding of PD pathogenesis are presented as they relate to selecting
 potential therapeutic targets, and issues with preclinical testing are described. We review recent innovations in clinical
 trial design, in...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1886768</comments>
            <pubDate>Thu, 16 Oct 2008 09:59:42 +0100</pubDate>
            <guid isPermaLink="false">1886768</guid>        </item>
        <item>
            <title>Many options for epilepsy: Comparisons of first- and second-generation AEDs</title>
            <link>http://www.medworm.com/index.php?rid=1886767&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fjr87585v15555580%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trials ReportDOI 10.1007/s11910-008-0049-3Authors
		Carl W. Bazil
	

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 8
	
		Journal Issue Volume 8, Number 4 / July, 2008 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1886767</comments>
            <pubDate>Thu, 16 Oct 2008 09:59:42 +0100</pubDate>
            <guid isPermaLink="false">1886767</guid>        </item>
        <item>
            <title>Pregnancy registries: What do they mean to clinical practice?</title>
            <link>http://www.medworm.com/index.php?rid=1886766&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb5n6354417272702%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Multiple surveillance pregnancy registries have been established in order to better understand the effects of antiepileptic
 drugs (AEDs) on pregnancy. These registries are either hospital based, population based, or pharmaceutical based and are primarily
 focused on the potential teratogenicity of AEDs. The main outcome variable for most of these registries is the risk of major
 congenital malformations. Registries also gather data on other aspects of pregnancy, including seizure control. The methodology
 of the registries varies. They have different populations, ascertainment strategies, follow-up, and reporting criteria. These
 differences limit the ability to allow direct comparisons. Overall, the registry data suggest that the overwhelming majority
 of women with e...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1886766</comments>
            <pubDate>Thu, 16 Oct 2008 09:59:42 +0100</pubDate>
            <guid isPermaLink="false">1886766</guid>        </item>
        <item>
            <title>Seizures, illicit drugs, and ethanol</title>
            <link>http://www.medworm.com/index.php?rid=1886765&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu7lxq1852t614424%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Recreational substance users are at risk for seizures by indirect mechanisms, including cerebral trauma, central nervous system
 infection, ischemic and hemorrhagic stroke, and metabolic derangements such as hypoglycemia, hypocalcemia, and renal failure.
 Drugs and ethanol can also cause seizures more directly, either as a feature of intoxication (eg, psychostimulants) or of
 withdrawal (eg, sedatives, including ethanol). In any patient with a seizure, clinicians should consider illicit drug or ethanol
 use. Seizures in known alcoholics or illicit drug users require workup to exclude treatable coexisting conditions.
 
	Content Type Journal ArticleDOI 10.1007/s11910-008-0051-9Authors
		John C. M. Brust, Harlem Hospital Center and Columbia University College of Physicians...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1886765</comments>
            <pubDate>Thu, 16 Oct 2008 09:59:42 +0100</pubDate>
            <guid isPermaLink="false">1886765</guid>        </item>
        <item>
            <title>Epilepsy and stigma: An update and critical review</title>
            <link>http://www.medworm.com/index.php?rid=1886764&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu4988166708074u7%2F</link>
            <description>This article discusses the concept of illness-related stigma and its relevance to consideration of the psychosocial impact
 of epilepsy. It provides an overview of the recent literature on epilepsy-related stigma as it relates to the stigma experience
 of people with epilepsy themselves and to the beliefs and attitudes held by other key target groups. The limitations of these
 and previous studies are considered, and some advances in knowledge arising from them are highlighted. Finally, some suggestions
 are made about possible areas for further investigation.
 
	Content Type Journal ArticleDOI 10.1007/s11910-008-0052-8Authors
		Ann Jacoby, University of Liverpool Division of Public Health Whelan Building, The Quadrangle, Brownlow Hill Liverpool L69 3GB UK
	

	
		Journal Current Neurology ...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1886764</comments>
            <pubDate>Thu, 16 Oct 2008 09:59:42 +0100</pubDate>
            <guid isPermaLink="false">1886764</guid>        </item>
        <item>
            <title>Neuroimaging and transcranial ultrasonography in Parkinson’s disease</title>
            <link>http://www.medworm.com/index.php?rid=1886773&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp506770491881338%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Parkinson’s disease is a progressive, widespread, neurodegenerative disease in which the involvement of the dopaminergic neurons
 of the substantia nigra results in significant dopamine depletion in the striatum. Newer imaging modalities reviewed here,
 using various radioligands, positron emission tomography, and single-photon emission computed tomography, have made it possible
 to assess the in vivo presynaptic and postsynaptic dopaminergic function. This is not only important from a diagnostic standpoint;
 these tests are being increasingly studied as surrogate markers to assess disease progression and responses to various interventions,
 including drugs. A brief comment on their role as a putative biomarker of the disease is also included. Because Parkinson’s
 d...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1886773</comments>
            <pubDate>Thu, 16 Oct 2008 09:59:41 +0100</pubDate>
            <guid isPermaLink="false">1886773</guid>        </item>
        <item>
            <title>An update on the pathophysiology and genetics of restless legs syndrome</title>
            <link>http://www.medworm.com/index.php?rid=1886772&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F0q1v582688x5x5rl%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;This update on restless legs syndrome (RLS) focuses on its pathophysiology, genetics, health impact, and treatment. Although
 symptoms are exquisitely responsive to dopaminergics, clear delineation of dopaminergic pathology has not emerged. Rather,
 heuristic models of alterations in spinal sensorimotor circuits and central nervous system iron deficiency are gaining more
 attention. Genome-wide association studies have recently identified polymorphisms in three genes with no obvious relationship
 to dopamine that account for 70% of the population risk for RLS. A single variant in the BTBD9 gene on chromosome 6 contributes to 50% of the population risk. Although the functions of BTBD9 remain uncertain, its biological plausibility is evidenced by its dose-dependent relati...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1886772</comments>
            <pubDate>Thu, 16 Oct 2008 09:59:41 +0100</pubDate>
            <guid isPermaLink="false">1886772</guid>        </item>
        <item>
            <title>Web alert</title>
            <link>http://www.medworm.com/index.php?rid=1886771&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq544058071502101%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s11910-008-0042-x

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 8
	
		Journal Issue Volume 8, Number 4 / July, 2008 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1886771</comments>
            <pubDate>Thu, 16 Oct 2008 09:59:41 +0100</pubDate>
            <guid isPermaLink="false">1886771</guid>        </item>
        <item>
            <title>An update on inherited ataxias</title>
            <link>http://www.medworm.com/index.php?rid=1886775&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn4kj615084076841%2F</link>
            <description>This article provides an overview of recent advances in the field of inherited ataxias. In the past few years, new causative
 mutations that broaden the diagnostic spectrum of ataxias have been described. In addition, important advances have unveiled
 the molecular pathology of these disorders, resulting in a classification based on the pathogenetic pathways rather than clinical
 or genetic features. As concepts of treatment principles emerge, debate continues as to whether such concepts might be applicable
 to more than one genetically defined disorder or whether each ataxia disorder requires its own unique therapeutic approach.
 New clinical assessment instruments have been developed that will facilitate future interventional trials. A recent phase
 2 clinical trial suggested a positive ...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1886775</comments>
            <pubDate>Thu, 16 Oct 2008 09:59:40 +0100</pubDate>
            <guid isPermaLink="false">1886775</guid>        </item>
        <item>
            <title>Value of genetic models in understanding the cause and mechanisms of Parkinson’s disease</title>
            <link>http://www.medworm.com/index.php?rid=1886774&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F77u627603k330242%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized pathologically by the degeneration of nigrostriatal
 pathway dopaminergic neurons and other neuronal systems and the appearance of Lewy bodies that contain α-synuclein. PD is
 generally a sporadic disease, but a small proportion of cases have a clear genetic component. Mutations have been identified
 in six genes that clearly segregate with disease in rare families with PD. Transgenic, knockout, and virus-based models of
 disease have been developed in rodents to further understand how these genes contribute to the pathogenesis of PD. In general,
 these animal models recapitulate many key features of the disease, including derangements in dopaminergic synaptic transmission,
 selective ...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1886774</comments>
            <pubDate>Thu, 16 Oct 2008 09:59:40 +0100</pubDate>
            <guid isPermaLink="false">1886774</guid>        </item>
        <item>
            <title>Web alert</title>
            <link>http://www.medworm.com/index.php?rid=1482299&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F5w360225r7l676x7%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s11910-008-0029-7

	
		Journal Current Neurology and Neuroscience ReportsOnline ISSN 1534-6293Print ISSN 1528-4042
	
		Journal Volume Volume 8
	
		Journal Issue Volume 8, Number 3 / May, 2008 (Source: Current Neurology and Neuroscience Reports)</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1482299</comments>
            <pubDate>Thu, 29 May 2008 06:55:50 +0100</pubDate>
            <guid isPermaLink="false">1482299</guid>        </item>
        <item>
            <title>Neurologic complications of antitumor antibody therapies</title>
            <link>http://www.medworm.com/index.php?rid=1482300&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv523h127418141r3%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Antibody-based therapy is being explored across a variety of disease types. Several successes in oncology have become part
 of standard care for diseases such as colorectal cancer and non-Hodgkin’s lymphoma. Traditional chemotherapeutic agents have
 had significant dose-limiting neurologic toxicities associated with their use. Although there are rare incidences of significant
 neurologic complications of antibody cancer therapy, these treatments are generally very well tolerated. Because most antibody
 therapy is adjunctive to other treatments, attribution to the immunologic component is often difficult to discern.
 
	Content Type Journal ArticleDOI 10.1007/s11910-008-0039-5Authors
		Teri N. Kreisl, National Cancer Institute Neuro-Oncology Branch 9030 Old Georgetown R...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1482300</comments>
            <pubDate>Thu, 29 May 2008 06:55:49 +0100</pubDate>
            <guid isPermaLink="false">1482300</guid>        </item>
        <item>
            <title>Neoplastic meningitis</title>
            <link>http://www.medworm.com/index.php?rid=1482301&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl511k64712316516%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Neoplastic meningitis (NM) occurs in approximately 5% of all patients with cancer. NM is a disease affecting the entire neuraxis,
 so staging and treatment need to encompass all cerebrospinal fluid (CSF) compartments. Central nervous system staging of NM
 includes contrast-enhanced brain and spine imaging and radionuclide CSF flow study. Treatment of NM incorporates involved-field
 radiotherapy of bulky or symptomatic disease sites and intra-CSF drug therapy. The inclusion of concomitant systemic therapy
 may benefit patients with NM and may obviate the need for intra-CSF chemotherapy. At present, intra-CSF drug therapy is confined
 to three chemotherapeutic agents (ie, methotrexate, cytosine arabinoside, and thiotepa) administered on a variety of schedules
 either by i...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1482301</comments>
            <pubDate>Thu, 29 May 2008 06:55:48 +0100</pubDate>
            <guid isPermaLink="false">1482301</guid>        </item>
        <item>
            <title>Cognition in brain tumor patients</title>
            <link>http://www.medworm.com/index.php?rid=1482302&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc238122w28352486%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;As effective treatment interventions have increased survival rates, there has been greater awareness that many brain tumor
 patients experience cognitive dysfunction despite adequate disease control. Cognitive difficulties often have an impact on
 quality of life and interfere with the patient’s ability to function at premorbid levels. A review of the literature indicates
 that whole-brain radiotherapy alone or in combination with chemotherapy results in more pronounced cognitive dysfunction than
 either partial radiotherapy or chemotherapy alone. Antiepileptic drugs and corticosteroids may also disrupt cognitive functioning.
 The cognitive domains suggested to be sensitive to treatment-induced cognitive dysfunction include attention and executive
 functions, memory, ...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1482302</comments>
            <pubDate>Thu, 29 May 2008 06:55:47 +0100</pubDate>
            <guid isPermaLink="false">1482302</guid>        </item>
        <item>
            <title>Drug delivery to brain tumors</title>
            <link>http://www.medworm.com/index.php?rid=1482303&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F48007x612073g237%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A prerequisite for the efficacy of any cancer drug is that it reaches the tumor in therapeutic concentrations. This is difficult
 to accomplish in most systemic solid tumors because of factors such as variable hypoxia, intratumoral pressure gradients,
 and abnormal vasculature within the tumors. In brain cancer, the situation is complicated by the blood-brain barrier (BBB)
 and blood-cerebrospinal fluid barrier, which serve as physical and physiologic obstacles for delivery of drugs to the central
 nervous system. Many approaches to overcome, circumvent, disrupt, or manipulate the BBB to enhance delivery of drugs to brain
 tumors have been devised and are in active investigation. These approaches include high-dose intravenous chemotherapy, intra-arterial
 drug delivery,...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1482303</comments>
            <pubDate>Thu, 29 May 2008 06:55:46 +0100</pubDate>
            <guid isPermaLink="false">1482303</guid>        </item>
        <item>
            <title>MicroRNAs in brain function and disease</title>
            <link>http://www.medworm.com/index.php?rid=1482307&amp;cid=s_35940_168_f&amp;fid=35940&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3262r0t86282rp86%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;MicroRNAs (miRNAs), a class of small, non-protein-coding transcripts about 21 nucleotides long, have recently entered center
 stage in the study of posttranscriptional gene regulation. They are now thought to be involved in the control of about one
 third of all protein-coding genes and play a role in the majority of cellular processes that have been studied. We focus on
 the role of the miRNA pathway in brain development, function, and disease by highlighting recent observations with respect
 to miRNA-mediated gene regulation in neuronal differentiation, synaptic plasticity, and the circadian clock. We also discuss
 the implications of these findings with respect to the involvement of miRNAs in the etiopathology of brain disorders and pinpoint
 the emerging therapeutic...</description>
            <author>Current Neurology and Neuroscience Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1482307</comments>
            <pubDate>Thu, 29 May 2008 06:55:44 +0100</pubDate>
            <guid isPermaLink="false">1482307</guid>        </item>
    </channel>
</rss>
